Thyroid dysfunction and diabetes mellitus: two closely associated disorders
Open accessAbstract
Thyroid dysfunction and diabetes mellitus are closely linked. Several studies have documented the increased prevalence of thyroid disorders in patients with diabetes mellitus and vice versa. This review critically discusses the different underlying mechanisms linking type 1 and 2 diabetes and thyroid dysfunction to demonstrate that the association of these two common disorders is unlikely a simple coincidence. We assess the current state of knowledge on the central and peripheral control of thyroid hormone on food intake and glucose and lipid metabolism in target tissues (such as liver, white and brown adipose tissue, pancreatic β cells, and skeletal muscle) to explain the mechanism linking overt and subclinical hypothyroidism to type 2 diabetes and metabolic syndrome. We also elucidate the common susceptibility genes and the pathogenetic mechanisms contributing to the autoimmune mechanism involved in the onset of type 1 diabetes mellitus and autoimmune thyroid disorders. An untreated thyroid dysfunction can impair the metabolic control of diabetic patients, and this association can have important repercussions on the outcome of both of these disorders. Therefore, we offer recommendations for the diagnosis, management, and screening of thyroid disorders in patients with diabetes mellitus, including the treatment of diabetic patients planning a pregnancy. We also discuss the major causes of failure to achieve an optimal management of thyroid dysfunction in diabetic patients and provide recommendations for assessing and treating these disorders during therapy with antidiabetic drugs. An algorithm for a correct approach of these disorders when linked is also provided.
AI snapshot
Written from the paper’s full text.
TL;DR
This review argues that thyroid dysfunction (TD) and diabetes mellitus (DM) are closely associated through shared autoimmunity, thyroid hormone effects on glucose/lipid metabolism, and drug interactions. It summarizes prevalence, mechanisms, prognosis, and management/screening recommendations, emphasizing that untreated TD can impair metabolic control in patients with diabetes.
Key findings
- Autoimmune thyroid disease occurs in 17% to 30% of adults with type 1 diabetes (T1D), and autoimmune hypothyroidism is present in 25% of children with T1D.
- TD is more common in type 2 diabetes (T2D) than in the general population; hypothyroidism prevalence in T2D ranges from 6% to 20%, and a meta-analysis found a 1.93-fold higher pooled prevalence of subclinical hypothyroidism in T2D versus healthy controls (95% CI, 1.66 to 2.24).
- Subclinical hypothyroidism in T2D was associated with increased risks of diabetic nephropathy (OR 1.74; 95% CI, 1.34 to 2.28), diabetic retinopathy (OR 1.42; 95% CI, 1.21 to 1.67), peripheral arterial disease (OR 1.85; 95% CI, 1.35 to 2.54), and diabetic peripheral neuropathy (OR 1.87; 95% CI, 1.06 to 3.28), but not coronary heart disease.
- Hyperthyroidism is found in 4.4% of adults with T2D, and subclinical hyperthyroidism in ~2% to 4%; preexisting DM is exacerbated by hyperthyroidism, and insulin treatment should be adjusted after TD occurs. Metformin lowers TSH in overt and subclinical hypothyroidism but not in euthyroid patients, with a TSH cut-off of 2.5 to 3 mU/L predicting the effect.
Methods
- Narrative review based on personal files, MEDLINE articles, meta-analyses, references of relevant articles and textbooks published from 1977 to 2018, and recent international guidelines.
- Search terms included thyroxine, triiodothyronine, hypothyroidism, hyperthyroidism, subclinical thyroid disease, type 1 and type 2 diabetes mellitus, insulin resistance, metabolic syndrome, gestational diabetes, prevalence, incidence, deiodinases, glucose metabolism, lipid metabolism, adipose tissue, appetite regulation, skeletal muscle, screening, morbidity, and mortality.
- The authors performed a critical assessment of the literature, agreed on inclusion/exclusion criteria, preferred high-quality papers, meta-analyses, randomized controlled and longitudinal trials, and discussed limitations in study design or execution when identified.
Limitations
- The paper states that limitations in study design or execution were discussed when identified, but it is a narrative review without new primary data and relies heavily on observational studies, meta-analyses, and guideline documents.
- The authors note insufficient evidence to determine specific screening tests, exact screening intervals, and cost-benefit for TD screening in T2D; they also note no prospective randomized controlled trial evaluating whether treating subclinical hyperthyroidism improves adverse outcomes.
- The text reports heterogeneity among included studies in meta-analyses of subclinical hypothyroidism and metabolic syndrome, conflicting results from Danish register-based studies on TD and diabetes incidence, and inconsistent findings on the D2 Thr92Ala polymorphism and insulin resistance/T2D.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 4 cited sources checked · 0 supported · 0 flagged
- Findingnone given
Asymptomatic thyroid dysfunction is common among T2D patients.
“Asymptomatic TD is frequently observed in patients with T2D.”
Quote in the paperSubstantial claim - Findingnone given
Diagnosing TD in T2D patients is difficult because certain oral diabetes drugs can interfere with serum TSH assessment.
“The diagnosis of TD in patients with T2D is difficult because some oral antidiabetic drugs can interfere with the evaluation of serum TSH levels.”
Quote in the paperNot a substantial claim - Premisenone given
Both hyperthyroidism and hypothyroidism can impair metabolic control in patients with diabetes.
“Both hyperthyroidism and hypothyroidism can impair the metabolic control in patients with diabetes.”
Quote in the paperNot a substantial claim - Premisereasoning
Thyroid dysfunction and diabetes mellitus are closely associated.
“Thyroid dysfunction and diabetes mellitus are closely linked.”
- Also stated in: § Abstract · plain
“DM and thyroid disease are two closely associated disorders.”
Quote in the paperSubstantial claim - Also stated in: § Abstract · plain
- Interpretationreasoning
The association between thyroid dysfunction and diabetes mellitus is unlikely to be a simple coincidence.
“to demonstrate that the association of these two common disorders is unlikely a simple coincidence.”
Quote in the paperSubstantial claim
- Premisecitation
Thyroid dysfunction is associated with changes in body weight and composition, body temperature, and total and resting energy expenditure independently of physical activity.
“TD is associated with changes in body weight and composition, body temperature, and total and resting energy expenditure independently of physical activity (, , ).”
Quote in the paperNot a substantial claim - Premisecitation
Correction of hyperthyroidism may cause excessive weight gain independent of treatment modality.
“Oppositely, the correction of hyperthyroidism may be responsible for excessive weight gain, independent of the treatment modality of thyrotoxicosis, that is, surgery, RAI, or ATDs ().”
Quote in the paperNot a substantial claim - Premisecitation
In healthy euthyroid middle-aged subjects, FT3 and FT4 levels and the FT3/FT4 ratio were associated with unfavorable metabolic profile and cardiovascular risk markers.
“In healthy euthyroid middle-aged subjects, FT and FT levels and the FT/ FT ratio were associated with various markers of unfavorable metabolic profile and cardiovascular risk ().”
Quote in the paperNot a substantial claim - Premisecitation
Morbidly obese individuals show a high prevalence of overt and subclinical autoimmune hypothyroidism, accounting for 19.5% of hypothyroidism.
“Alternatively, individuals who are morbidly obese show a high prevalence of overt and subclinical autoimmune hypothyroidism, accounting for .% of hypothyroidsm (, ).”
Quote in the paperNot a substantial claim - Premisecitation
Thyroid hormone regulates both obligatory and adaptive thermogenesis by raising basal metabolic rate and modulating sympathetic activation of brown adipose tissue.
“The TH plays a major role in regulating both obligatory and adaptive thermogenesis by increasing the basal metabolic rate and by modulating the sympathetic nervous system activation of BAT (, ) (Fig. ).”
Quote in the paperNot a substantial claim - Premisecitation
Indices of insulin resistance are closely linked to TSH and thyroid hormone levels even within the normal range in euthyroid eumetabolic subjects.
“Indices of insulin resistance are closely linked to TSH and TH levels, even within the normal range in euthyroid eumetabolic subjects (, -).”
Quote in the paperSubstantial claim - Premisecitation
In a Korean study of 6241 nondiabetic euthyroid subjects, those in the lowest FT4 quartile had twice the risk of insulin resistance compared with the highest quartile after adjusting for age, sex, metabolic, and lifestyle factors.
“In a Korean study on nondiabetic euthyroid subjects, those with the lowest FT quartile had twice the risk of insulin resistance when compared with those in the highest quartile after adjusting for age, sex, metabolic, and lifestyle factors ().”
Quote in the paperNot a substantial claim - Premisecitation
Slight variations in thyroid function, even within the laboratory reference range, can be associated with regional obesity and a tendency to gain weight.
“Moreover, slight variations in thyroid function, even within the laboratory reference range, can be associated with the development of regional obesity and the tendency to gain weight (, ).”
Quote in the paperNot a substantial claim - Premisecitation
Reduced hepatic LDL receptor gene expression may contribute to hypercholesterolemia in hypothyroidism.
“Reduced expression of the hepatic LDL receptor gene, responsible for an impaired cholesterol clearance, may contribute to hypercholesterolemia in patients with hypothyroidism ().”
Quote in the paperNot a substantial claim - Interpretationreasoning
Current evidence suggests that treating thyroid dysfunction in patients with diabetes improves prognosis.
“Current evidence suggests the necessity of treating TD in patients with DM to improve their prognosis.”
Quote in the paperNot a substantial claim - Premisecitation
T3 regulates metabolism and thermogenesis by controlling transcription factors in adipogenesis, appetite, and glucose and lipid metabolism.
“T influences both metabolism and thermogenesis by regulating (i) transcription factors involved in adipogenesis of WAT and BAT, (ii) appetite, and (iii) glucose and lipid metabolism and oxidation (, , , ).”
Quote in the paperNot a substantial claim - Premisecitation
POMC neurons from the arcuate nucleus activate BDNF neurons in the ventromedial nucleus to decrease food intake.
“The VMN receives NPY/AgRP, and POMC neuronal projections from the ARC and POMC neurons from the ARC play a role in activating BDNF neurons in the VMN to decrease the food intake ().”
Quote in the paperNot a substantial claim - Premisecitation
Elevated triglycerides in hypothyroidism are due to decreased hepatic triglyceride lipase activity.
“The elevation of triglycerides in hypothyroidism is due to a decrease in the activity of hepatic triglyceride lipase ().”
Quote in the paperNot a substantial claim - Premisecitation
The arcuate nucleus receives energy-status information from peripheral factors including leptin, insulin, pancreatic polypeptide, gut hormones, and T3.
“This area is not fully protected from the circulation by the blood-brain barrier and receives information regarding energy status from peripheral circulating factors produced by peripheral organs such as leptin by adipose tissue, insulin and pancreatic polypeptide by the pancreas, gut hormones (ghrelin, obestatin, GLP-, oxyntomodulin, peptide YY), and T by the thyroid gland (, ).”
Quote in the paperNot a substantial claim - Premisecitation
Raising TSH levels has been linked to a progressive increase in weight over time.
“Moreover, raising TSH levels has been linked to a progressive increase in weight over time ().”
Quote in the paperNot a substantial claim - Premisecitation
During cold exposure, D2 increases T3 generation in brown adipose tissue, promoting heat production.
“During cold exposure, D increases the generation of T in BAT, thus promoting heat production ().”
Quote in the paperNot a substantial claim - Premisecitation
In vivo, recombinant human TSH at supraphysiological doses can induce release of small but significant amounts of leptin proportional to adipose mass.
“In vivo, the administration of recombinant human TSH at supraphysiological doses can induce the release of small, but significant amounts of leptin, which are proportional to the adipose mass ().”
Quote in the paperNot a substantial claim - Premisecitation
In the NHANES 2007-2008 analysis of 3114 euthyroid healthy men and women, TSH and FT3 levels correlated with BMI and waist circumference.
“The NHANES - analysis of euthyroidhealthy men and women showed that TSH levels and FT were correlated with BMI and waist circumference ().”
Quote in the paperNot a substantial claim - Premisecitation
Central T3 administration in rats activates the sympathetic nervous system and upregulates brown adipose tissue thermogenesis by reducing hypothalamic AMPK activity.
“A central administration of T in rats leads to sympathetic nervous system activation and upregulation of BAT thermogenesis via the reduction in the hypothalamic AMP-activated protein kinase activity.”
Quote in the paperNot a substantial claim - Premisecitation
Leptin administration to normal-weight rodents dramatically reduces food intake and body weight by activating anorectic POMC neurons and inhibiting orexigenic AgRP/NPY neurons.
“The administration of leptin to normal weight rodents produces a dramatic reduction in food intake and body weight because leptin directly activates anorectic POMC neurons and inhibits orexigenic AgRP/NPY neurons ().”
Quote in the paperNot a substantial claim - Premisecitation
Hyperthyroidism is usually associated with a variable decrease in body weight despite increased appetite because total energy expenditure rises.
“Despite increased appetite, hyperthyroidism is usually associated with a variable decrease in body weight owing to the increase in total energy expenditure ().”
Quote in the paperNot a substantial claim - Premisecitation
In rodent models, peripheral and central hypothalamic administration of T3 increases food intake.
“In rodent models, peripheral and central hypothalamic administration of T increases food intake ().”
Quote in the paperNot a substantial claim - Premisecitation
Functional imaging with positron emission tomography has shown brown adipose tissue activation after overnight cold exposure.
“Although the importance of BAT for metabolic regulation in adults is controversial, functional imaging by positron emission tomography scan has demonstrated BAT activation after overnight cold exposure ().”
Quote in the paperNot a substantial claim - Premisecitation
Leptin can regulate D2, activating conversion of T4 to T3.
“Leptin can also regulate D, activating the conversion of T to T ().”
Quote in the paperNot a substantial claim - Premisecitation
Direct administration of T3 into the ventromedial nucleus increases food intake in rats.
“Direct administration of T into the VMN increases food intake in rats ().”
Quote in the paperNot a substantial claim - Premisecitation
Obesity can induce insulin resistance and diabetes because adipose tissue is an active endocrine tissue releasing free fatty acids, leptin, adiponectin, resistin, and other products that affect glucose and lipid metabolism.
“Obesity can induce insulin resistance and diabetes because the adipose tissue is an active endocrine tissue; it releases free fatty acids, leptin, adiponectin, resistin, and other products that play an important major role in glucose and lipid metabolism ().”
Quote in the paperNot a substantial claim - Premisecitation
In rodents, central and peripheral administration of TRH reduces food intake.
“In rodents, central and peripheral administration of TRH reduces food intake ().”
Quote in the paperNot a substantial claim - Premisecitation
The hyperthyroidism-induced increase in food intake is reversed by central treatment with rapamycin, resulting in weight loss.
“The hyperthyroidism-induced increase in food intake is reversed by central treatment with the specific mTOR inhibitor rapamycin, resulting in weight loss (, , ).”
Quote in the paperNot a substantial claim - Premisecitation
Hypothyroid patients on adequate L-T4 usually have only modest or transient weight loss mainly from excreting excess body water rather than losing fat mass.
“hypothyroid patients usually have only a modest and/or transient weight loss prevalently due to the excretion of excess body water, rather than reduction in fat mass ().”
Quote in the paperNot a substantial claim - Premisecitation
An increased risk of pregnancy complications is also associated with subclinical hypothyroidism, especially in TPO Ab-positive women.
“An increased risk of pregnancy complications is also associated with SHypo, especially in TPO Ab-positive women (-).”
Quote in the paperNot a substantial claim - Premisecitation
A greater prevalence of diabetic nephropathy was reported in a cross-sectional analysis of 588 patients with type 2 diabetes and subclinical hypothyroidism compared with euthyroid individuals.
“A greater prevalence of DN was reported in a cross-sectional analysis on patients with TD and SHypo compared with euthyroid individuals ().”
Quote in the paperSubstantial claim - Premisecitation
Pregnant women with hypothyroidism or isolated hypothyroxinemia can have adverse metabolic characteristics such as raised blood glucose, HbA1c, insulin resistance, and gestational diabetes.
“Alternatively, pregnant women with hypothyroidism or isolated hypothyroxinemia can have adverse metabolic characteristics (e.g., raised blood glucose, HbAc, insulin resistance, and gestational diabetes) (-).”
Quote in the paperSubstantial claim - Premisecitation
Pregnant women with a family history of diabetes have a much higher incidence of gestational diabetes mellitus than those without.
“Moreover, pregnant women with a family history of diabetes have a much higher incidence of GDM than do those without a family history of diabetes (-).”
Quote in the paperNot a substantial claim - Premisecitation
Two meta-analyses of cross-sectional studies concluded that subclinical hypothyroidism might be associated with increased risk of metabolic syndrome.
“Two meta-analysis of cross-sectional studies concluded that SHypo might be associated with an increased risk of MetS (, ).”
Quote in the paperNot a substantial claim - Premiseown data
A significant increase in odds of having metabolic syndrome was found in participants with marked subclinical hypothyroidism (TSH 10 to 20 mU/L).
“A significant increase in the odds of having MetS was found in participants with marked SHypo (TSH to mU/L).”
Quote in the paperSubstantial claim - Premisecitation
A meta-analysis of eight epidemiological studies confirmed that subclinical hypothyroidism increased the risk of diabetic retinopathy by 2.13-fold (95% CI 1.41-3.23; P<0.001) compared with euthyroid individuals.
“A meta-analysis including eight epidemiological studies confirmed this association showing that the onset of SHypo increased the risk of DR by .-fold (% CI, . to .; P , .) compared with euthyroid individuals ().”
Quote in the paperSubstantial claim - Premisecitation
The incidence of type 2 diabetes in pregnant women increases with maternal age and increasing prepregnancy BMI.
“The incidence of TD in pregnant women is increased with both maternal age and increasing prepregnancy BMI (-).”
Quote in the paperNot a substantial claim - Premisecitation
Follow-up testing of serum T4 in persons with persistently abnormal TSH levels can differentiate between subclinical and overt thyroid dysfunction.
“Follow-up testing of serum T levels in persons with persistently abnormal TSH levels can differentiate between subclinical (normal T) and overt (abnormal T) TD ().”
Quote in the paperNot a substantial claim - Premisecitation
Patients with poorly controlled diabetes may have up to a 50% increased risk of pregnancy loss.
“Patients with poorly controlled DM may have up to a % increased risk of pregnancy loss ().”
Quote in the paperNot a substantial claim - Premisecitation
Another meta-analysis using Adult Treatment Panel III criteria found no significant difference in metabolic syndrome prevalence between subclinical hypothyroidism and euthyroid individuals (OR 1.13; 95% CI 0.95-1.34).
“Although this study did not report a significant difference in MetS prevalence between individuals with SHypo and euthyroid individuals (OR, .; % CI, . to .), the prevalence of central obesity (OR, .; % CI, . to .) was significantly higher in the group with SHypo, and hypertriglyceridemia was prevalent in the female group with SHypo ().”
Quote in the paperNot a substantial claim - Premisecitation
Subclinical hypothyroidism and high serum TSH levels were associated with nonalcoholic fatty liver disease.
“Moreover, SHypo and high serum TSH levels were associated with nonalcoholic fatty liver disease (-).”
Quote in the paperNot a substantial claim - Premiseown data
The pooled odds ratio for diabetic peripheral neuropathy was 1.87 (95% CI 1.06-3.28) pooling three studies with 420 type 2 diabetes patients with subclinical hypothyroidism and 1290 euthyroid type 2 diabetes patients.
“The pooled OR for DPN was . (% CI, . to .) when pooling data from three studies that included of individuals with TD with SHypo and euthyroid individuals with TD.”
Quote in the paperSubstantial claim - Premisecitation
Thyroid hormone and daily iodine requirements increase during pregnancy because of changes in thyroid function and renal iodine excretion.
“TH and daily iodine requirements increase during pregnancy because of important changes in the thyroid function and renal iodine excretion (-).”
Quote in the paperNot a substantial claim - Premisecitation
Subclinical hypothyroidism was considered a risk factor for metabolic syndrome.
“SHypo was considered a risk factor for MetS ().”
Quote in the paperNot a substantial claim - Premisecitation
Insulin resistance, diastolic hypertension, increased systemic vascular resistance, increased arterial stiffness, endothelial dysfunction, and altered coagulability are the main risk factors responsible for increased cardiovascular mortality associated with thyroid hormone deficiency.
“Insulin resistance, diastolic hypertension, increased systemic vascular resistance, increased arterial stiffness, endothelial dysfunction, and altered coagulability represent the main risk factors responsible for the increased cardiovascular mortality associated with TH deficiency ().”
Quote in the paperNot a substantial claim - Premisecitation
Women with gestational diabetes are at high risk of developing chronic hypertension and vascular complications.
“Additionally, women with GDM are at a high risk of developing chronic hypertension and vascular complications (, ).”
Quote in the paperNot a substantial claim - Premisecitation
In that meta-analysis, central obesity prevalence was significantly higher in the subclinical hypothyroidism group (OR 1.43; 95% CI 1.04-1.96).
“Although this study did not report a significant difference in MetS prevalence between individuals with SHypo and euthyroid individuals (OR, .; % CI, . to .), the prevalence of central obesity (OR, .; % CI, . to .) was significantly higher in the group with SHypo, and hypertriglyceridemia was prevalent in the female group with SHypo ().”
Quote in the paperNot a substantial claim - Premisecitation
Patients with diabetes have up to a sixfold higher risk of future coronary heart disease events compared with nondiabetic individuals.
“Patients with diabetes have up to a sixfold higher risk of future CHD events compared with nondiabetic individuals (-).”
Quote in the paperNot a substantial claim - Premiseown data
The pooled odds ratio for peripheral arterial disease was 1.85 (95% CI 1.35-2.54) pooling four studies with 312 cases and 489 controls.
“The pooled OR for PAD was . (% CI, . to .) when pooling data from four studies that included cases and controls.”
Quote in the paperSubstantial claim - Premisecitation
A meta-analysis of 36 articles assessed complications in patients with type 2 diabetes and subclinical hypothyroidism.
“A meta-analysis of articles assessed the prevalence of complications in patients with TD with SHypo ().”
Quote in the paperSubstantial claim - Premisecitation
The prevalence of metabolic syndrome decreased significantly from higher to lower FT4 tertiles within the euthyroid range (30.1% in lowest to 22.4% in highest; P<0.001).
“Interestingly, the prevalence of MetS decreased significantly from the higher to lower FT tertiles within the euthyroid range (.% in the lowest FT tertile to .% in the highest FT tertile) (P , .) ().”
Quote in the paperSubstantial claim - Premisecitation
The coexistence of type 2 diabetes and thyroid diseases could further increase the risk of coronary heart disease.
“The coexistence of both TD and thyroid diseases could further increase the risk of CHD ().”
Quote in the paperSubstantial claim - Premisecitation
The risk for gestational diabetes is increased even in women with high TSH levels within the normal reference range.
“The risk for gestational diabetes is increased even in women with high TSH levels within the normal reference range ().”
Quote in the paperSubstantial claim - Premiseown data
The odds ratio for coronary heart disease was 1.59 (95% CI 0.92-2.76) pooling 10 studies with 579 type 2 diabetes patients with subclinical hypothyroidism and 1317 euthyroid type 2 diabetes patients.
“The OR for CHD was . (% CI, . to .) when pooling data from studies that included individuals with TD with SHypo and euthyroid individuals with TD.”
Quote in the paperSubstantial claim - Premisecitation
Typing of MHC HLA class II DR/DQ antigens and testing PTPN22 and CTLA-4 SNPs help differentiate between polyglandular and monoglandular autoimmunity.
“Typing of the MHC HLA class II DR/DQ antigens and eventually testing the PTPN and CTLA- SNPs help differentiate between patients with polyglandular vs monoglandular autoimmunity (, , ).”
Quote in the paperNot a substantial claim - Interpretationreasoning
A considerable overlap may occur in the pathogenetic mechanisms of atherosclerotic disease correlated with metabolic syndrome and hypothyroidism.
“Consequently, a considerable overlap may occur in the pathogenetic mechanisms of atherosclerotic disease correlated with MetS and hypothyroidism (Fig. ).”
Quote in the paperSubstantial claim - Premisecitation
An association has been reported between overt hypothyroidism during pregnancy and subsequent diabetes morbidity later in life.
“An association has been reported between overt hypothyroidism during pregnancy and subsequent diabetes morbidity later in life ().”
Quote in the paperNot a substantial claim - Premisecitation
Two meta-analyses found that systolic and diastolic blood pressure were higher in the subclinical hypothyroidism group than in euthyroid controls.
“Two meta-analyses found that systolic (, ) and diastolic blood pressure () were higher in the group with SHypo than in euthyroid controls.”
Quote in the paperNot a substantial claim - Premisecitation
In that meta-analysis, the odds ratio for diabetic nephropathy was 1.74 (95% CI 1.34-2.28) pooling 10 studies with 869 type 2 diabetes patients with subclinical hypothyroidism and 3892 euthyroid type 2 diabetes patients.
“The OR for DN was . (% CI, . to .) when pooling data from studies, which included individuals with TD with SHypo compared with euthyroid individuals with TD.”
Quote in the paperSubstantial claim - Premisenone given
Certain oral diabetes medications can interfere with serum TSH measurement.
“some oral antidiabetic drugs interfere with the evaluation of serum TSH levels”
Quote in the paperNot a substantial claim - Premiseown data
The odds ratio for diabetic retinopathy was 1.42 (95% CI 1.21-1.67) pooling 10 studies with 835 type 2 diabetes patients with subclinical hypothyroidism and 3737 euthyroid type 2 diabetes patients.
“The OR for DR was . (% CI, . to .) when pooling the results from studies that enrolled individuals with TD with SHypo and euthyroid individuals with TD.”
Quote in the paperSubstantial claim - Premisecitation
Subclinical hypothyroidism is linked to diabetic retinopathy.
“SHypo is linked to DR (, ).”
Quote in the paperSubstantial claim - Premisecitation
The incidence of gestational diabetes decreased in women with higher FT4 levels, showing a protective effect for development of gestational diabetes.
“Conversely, the incidence of GDM decreased in women with higher FT levels, showing a protective effect for the development of GDM ().”
Quote in the paperSubstantial claim - Premisecitation
The coexistence of diabetes and thyroid disorders may worsen the risk of diabetic retinopathy and diabetic nephropathy in patients with diabetes.
“The coexistence of both diabetes and thyroid disorders may worsen the risk of diabetic retinopathy (DR) and diabetic nephropathy (DN) in patients with diabetes (-).”
Quote in the paperSubstantial claim - Interpretationcitation
The reviewed data suggest that metabolic abnormalities are more prevalent as serum TSH increases.
“All of these data suggest that there is a higher prevalence of metabolic abnormalities with increasing serum TSH levels.”
Quote in the paperSubstantial claim - Premisecitation
In a German euthyroid cohort (mean age 52), TSH in the upper normal range (2.5-4.5 mU/L) was associated with a 1.7-fold increased risk of metabolic syndrome compared with low-normal TSH (0.3-2.5 mU/L).
“A study on a euthyroid German cohort (mean age years) found that TSH in the upper normal range (. to . mU/L) was associated with a .-fold increased risk of MetS compared with a lownormal TSH (. to . mU/L) ().”
Quote in the paperSubstantial claim - Interpretationcitation
The high cardiovascular risk may be further increased when metabolic syndrome is associated with thyroid hormone deficiency.
“This high cardiovascular risk could be further increased when metabolic syndrome is associated with TH deficiency ().”
Quote in the paperNot a substantial claim - Premisecitation
A meta-analysis of six cohort studies showed that the incidence of gestational diabetes in patients with subclinical hypothyroidism was 1.35-fold higher than in controls.
“A meta-analysis of six cohort studies showed that the incidence of GDM in patients with SHypo was .-fold higher than the incidence in the control group ().”
Quote in the paperSubstantial claim - Interpretationreasoning
Detecting TD through screening may enable early treatment that prevents severe cardiovascular and metabolic complications.
“the screening of TD may allow early treatment, preventing high cardiovascular and metabolic complications”
Quote in the paperSubstantial claim - Premisecitation
Even high-normal serum TSH and low-normal free T4 levels have been significantly associated with increased prevalence of metabolic syndrome.
“Even high-normal serum TSH levels and low-normal free T levels have been significantly associated with increased prevalence of MetS ().”
Quote in the paperNot a substantial claim - Premisecitation
The prevalence of metabolic syndrome was 44% in hypothyroidism and 35% in subclinical hypothyroidism compared with 33% in controls (P=0.016).
“The prevalence of MetS was reported to be % in patients with hypothyroidism and % in patients with SHypo compared with % in the control group (P = .)().”
Quote in the paperNot a substantial claim - Premisecitation
A prospective study of 6031 Chinese pregnant women showed that low FT4 levels during pregnancy were a risk factor for gestational diabetes and preeclampsia.
“A prospective study of Chinese pregnant women showed that low FT levels during pregnancy were a risk factor for GDM and preeclampsia ().”
Quote in the paperSubstantial claim - Premisecitation
In 1000 euthyroid postmenopausal Korean women (mean age 59), the odds ratio for metabolic syndrome was 1.9 in the highest versus lowest TSH quartiles.
“Another study on euthyroid postmenopausal women in Korea (mean age years) reported an OR for MetS of . in participants with the highest vs lowest quartiles of TSH ().”
Quote in the paperSubstantial claim - Premisecitation
Hypothyroidism can be responsible for adverse pregnancy outcomes and offspring complications.
“Hypothyroidism can be responsible for a variety of adverse effects in pregnancy outcomes and offspring-and pregnancyrelated complications (, ).”
Quote in the paperNot a substantial claim - Interpretationnone given
The onset of thyroid dysfunction can further increase the long-term morbidity and mortality associated with diabetes.
“The onset of TD can further increase the long-term morbidity and mortality associated with diabetes.”
Quote in the paperSubstantial claim - Premisecitation
Higher FT4 values were associated with lower odds of metabolic syndrome (OR 0.96; 95% CI 0.92-0.99; P=0.01).
“Higher FT values were associated with lower odds of MetS (OR, .; % CI, . to .; P = .)().”
Quote in the paperSubstantial claim
- May combine two claims. 46
- Classified as probably not a substantial claim. 6
May combine two claims.
Interpretationnone givenUntreated thyroid dysfunction can impair metabolic control in diabetic patients and affect the outcome of both disorders.
“An untreated thyroid dysfunction can impair the metabolic control of diabetic patients, and this association can have important repercussions on the outcome of both of these disorders.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationThe prevalence of thyroid disorders is increased in patients with diabetes mellitus and vice versa.
“Several studies have documented the increased prevalence of thyroid disorders in patients with diabetes mellitus and vice versa.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationUCP1 expression is required for brown adipose tissue thermogenesis and is synergistically regulated by noradrenaline and T3.
“The expression of UCP is required for BAT thermogenesis, and UCP is synergistically regulated by both noradreanaline and T ().”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationHigh circulating insulin may induce increased thyroid proliferation, larger thyroid volume, and nodule formation.
“Regarding the effects of insulin on the thyroid gland, high circulating levels of insulin may induce increased thyroid proliferation with the development of larger thyroid volume and the formation of nodules.This goitrogenic action of insulin may explain why the thyroid gland was considered another victim of the insulin resistance syndrome ().”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationBoth autoimmune thyroid disease and female sex are risk factors for progression of thyroid dysfunction among patients with diabetes.
“Both AITD and female sex are risk factors for progression of TD among patients with diabetes.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationWeight excess was reported in 54% of patients with overt hypothyroidism, reflecting body fat accumulation from decreased resting energy expenditure and increased body water from reduced free water excretion.
“Regarding hypothyroidism, weight excess was reported in % patients with overt hypothyroidism, reflecting both the accumulation of body fat, due to decreased resting energy expenditure, and the increased water content of the body, consequent to a reduced capacity of excreting free water ().”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
InterpretationcitationThe similar effects of leptin and insulin on food intake may be mediated by a common IRS/phosphatidylinositol-3-OH kinase pathway in the hypothalamus.
“It is interesting that this IRS/ phosphatidylinositol--OH kinase pathway is also activated by leptin, and therefore the similar effects of leptin and insulin on food intake may be mediated via this common pathway in the hypothalamus ().”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationCentral infusion of BDNF reduces food intake and induces weight loss in rats.
“The central infusion of BDNF reduces food intake and induces weight loss in rats ().”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationOvert hypothyroidism is associated with hyperlipidemia, and subclinical hypothyroidism has been related to plasma lipid alterations, although results are conflicting.
“Overt hypothyroidism is associated with hyperlipidemia, and even SHypo has been related to alterations in plasma lipids, although with conflicting results ().”
Quote in the paperNot a substantial claimMay combine two claims.
PremisereasoningType 1 diabetes is closely associated with autoimmune-induced thyroid dysfunction because both conditions share the same pathophysiological mechanism.
“This disorder is closely associated with autoimmune-induced TD in clinical practice because these endocrine diseases are linked by the same pathophysiological mechanism.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationcitationThe correlation between TSH and BMI could be mediated by leptin because serum leptin and TSH are positively correlated in obese individuals, and TSH can stimulate leptin secretion by human adipose tissue via TSH receptors on adipocytes.
“The correlation between TSH and BMI could be mediated by leptin produced by adipose tissue because a positive correlation has been identified between serum leptin and serum TSH levels in individuals who are obese.TSH in turn can stimulate leptin secretion by human adipose tissue via TSH receptors that are expressed on adipocytes (, , ).”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationBoth subclinical and overt hypothyroidism are frequently associated with weight gain, decreased thermogenesis, and decreased metabolic rate.
“Both subclinical and overt hypothyroidism are frequently associated with weight gain, decreased thermogenesis, and metabolic rate (, ).”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationCentral T3 activates mTOR signaling and is associated with increased AgRP and NPY expression and decreased POMC expression in the hypothalamic arcuate nucleus.
“In fact, T can directly cross the blood-brain barrier, and the central administration of T activates the mTOR signaling pathway and is associated with increased expression of AgRP and NPY, as well as decreased POMC expression in hypothalamic ARC (, ).”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationTH has insulin-antagonistic effects in the liver and synergistic effects with insulin in peripheral tissues.
“TH has insulin-antagonistic effects in the liver, whereas it acts synergically with insulin in the peripheral tissues.”
Quote in the paperSubstantial claim0 of 2 sources checkedMay combine two claims.
PremisecitationIsolated hyperthyrotropinemia is frequently observed in obese patients and is spontaneously reversible by weight loss without specific treatment.
“Isolated hyperthyrotropinemia is frequently observed in patients who are obese.It is a condition spontaneously reversible by losing weight without the necessity of specific treatment; in fact, it is usually associated with FT levels that are at the upper limit of the normal range ().”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationAn increase in total cholesterol and its subfractions is common in hypothyroidism, and a direct relationship between serum TSH and total cholesterol has been described.
“An increase of total cholesterol and its subfractions is a common finding in hypothyroidism, and a direct relationship between serum TSH and total cholesterol levels has been described ().”
Quote in the paperNot a substantial claimMay combine two claims.
Premisenone givenThyroid hormone exerts profound effects on the regulation of glucose homeostasis and lipid metabolism.
“TH exerts profound effects on the regulation of glucose homeostasis and lipid metabolism.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationTSH injected centrally into rats reduces food intake and may be involved in seasonal changes in food intake and body weight.
“TSH has also been shown to reduce food intake when injected centrally into rats and could be involved with the seasonal alterations in food intake and body weight that occur in some species (, ).”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationInsulin administered intracerebroventricularly reduces food intake and body weight, and its anorectic effect involves insulin receptors on arcuate neurons.
“Insulin has anorectic effects in the central nervous system and its ICV administration reduces food intake and body weight () (Fig. ).Its anorectic effect involves insulin receptors on ARC neurons ().”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningMitochondrial dysfunction may be a common mechanism linking diabetes mellitus and thyroid dysfunction that can be aggravated by statins.
“Mitochondrial dysfunction can represent the common mechanism related to both DM and TD that can be aggravated by statins.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationThyroid hormones modulate cholesterol synthesis, mobilization, and breakdown; they increase cholesterol synthesis via HMG-CoA reductase and stimulate removal by enhancing hepatic LDL receptor expression.
“THs modulate cholesterol synthesis, mobilization, and breakdown.In particular, they increase cholesterol synthesis via the rate-limiting enzyme -OHmethylglutaryl coenzyme A reductase and, in turn, stimulate its removal by enhancing the expression of low-density lipoprotein (LDL) receptors in the liver ().”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationIn the HUNT Study of 30,656 euthyroid individuals, serum TSH within the euthyroid range was positively and significantly associated with total cholesterol, LDL-C, and triglycerides, and inversely associated with HDL-C.
“In the HUNT Study, among , euthyroid individuals, serum TSH levels within the euthyroid range were positively and significantly associated with total cholesterol, LDL-C, and triglycerides, with an inverse relationship between serum TSH and HDL-C ().”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationMetabolic syndrome independently raises the risk of cardiovascular disease and type 2 diabetes.
“A prothrombotic state and a proinflammatory state are usually associated with MetS, which is as an independent risk factor for CVDs and TD (, ).”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationT3 and noradrenaline separately double UCP1 expression, but combined they induce a 20-fold increase.
“T and noradreanaline increase UCP expression by twofold separately.On the contrary, when both agents are combined they induce a -fold expression of UCP ().”
Quote in the paperNot a substantial claimMay combine two claims.
Premisenone givenT3-treated rats have lower plasma leptin, fourfold higher hypothalamic NPY mRNA, and about 80% lower hypothalamic POMC and CART mRNA than controls.
“T-treated rats have significantly lower plasma leptin levels compared with control rats; hypothalamic expression of NPY mRNA is increased fourfold, and hypothalamic POMC and CART mRNA are reduced by ~%, compared with control rats.”
Quote in the paperSubstantial claimMay combine two claims.
PremisereasoningThyroid hormones affect food intake, resting energy expenditure, and thermogenesis, so metabolic alterations can develop in thyroid dysfunction.
“TH affects food intake, resting energy expenditure, and thermogenesis, and consequently metabolic alterations can develop in patients with TD.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationHypothyroidism is a risk factor for incident chronic kidney disease, progression of chronic kidney disease, and higher death risk in kidney disease patients.
“A growing body of evidence suggests that hypothyroidism is a risk factor for incident chronic kidney disease, progression of chronic kidney disease , and higher death risk in kidney disease patients (, ).”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationThe combination of high serum TSH and thyroid autoimmunity in early pregnancy was associated with a fourfold increased risk for gestational diabetes (RR 4.3; 95% CI 2.1-8.9) and a threefold increased risk for low birth weight neonates (RR 3.1; 95% CI 1.2-8.0) after adjustment for confounders.
“Conversely, the combination of high serum TSH and thyroid autoimmunity in early pregnancy was associated with a fourfold increased risk for GMD (RR, .; % CI, . to .) and a threefold increased risk for low birth weight neonates (RR, .; % CI, . to .) after adjustment for several confounders ().”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationDiabetes caused 1.5 million deaths in 2012, with excess relative mortality risk ranging from 1.15 to 3.15, mainly from cardiovascular causes.
“DM caused . million deaths in , with an excess relative risk of mortality, ranging from . to ., mainly attributable to cardiovascular causes (-).”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationBoth metabolic syndrome and hypothyroidism are independent risk factors for cardiovascular disease.
“Both MetS and hypothyroidism are independent risk factors for CVDs ().”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationcitationThe authors of that meta-analysis concluded that subclinical hypothyroidism is prevalent in type 2 diabetes and may be responsible for greater risk of diabetic nephropathy, retinopathy, peripheral arterial disease, and peripheral neuropathy, but not coronary heart disease.
“Therefore, the authors concluded that SHypo is prevalent in patients with TD and may be responsible for a greater risk of diabetic complications such as DN, DR, PAD, and DPN, but not CHD ().”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationHigher TSH levels were associated with higher triglycerides and lower HDL, and this relationship was stronger among overweight individuals (BMI >25 kg/m2).
“Higher TSH levels were also associated with higher triglycerides and lower HDL; furthermore, this relationship was stronger among individuals who were overweight (BMI .kg/m ) ().”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningCurrent evidence is insufficient to determine which screening tests to use, how often to screen, and whether the benefits outweigh the costs for TD screening in patients with T2D.
“There are insufficient data to assess the specific tests for screening (TSH alone, TSH and TPO, or TSH and FT4), the exact interval of periodic screening, and the cost-benefit ratio.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationSevere maternal hypothyroidism is associated with increased risk of adverse pregnancy complications (fetal death, premature birth, low birth weight, pregnancy loss, gestational hypertension) and detrimental effects on fetal neurocognitive development, leading to lower IQ in offspring.
“Severe maternal hypothyroidism is associated with an increased risk of adverse pregnancy complications (fetal death, premature birth, low birth weight, pregnancy loss, and gestational hypertension) as well as detrimental effects on fetal neurocognitive development, leading to a lower intelligence quotient in the offspring (-).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe prevalence of gestational diabetes mellitus in pregnant women ranges from 1.7% to 20%, varying by country, screening strategy, and diagnostic criteria.
“The prevalence of GDM in pregnant women ranges from .% to %, with a wide difference according to country, screening strategy, and diagnostic criteria (, -).”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationThyroid dysfunction was observed in 22.5% of women with type 1 diabetes in the first trimester and 18.4% in the third trimester; the prevalent form was subclinical or overt hypothyroidism.
“TD was observed in .% of women with TD in the first trimester and .% in the third trimester; the prevalent form of TD was subclinical or overt hypothyroidism ().”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationThe incidence of thyroid dysfunction during pregnancy in women with type 1 diabetes is threefold higher than in the general population, particularly in the first trimester and first year postpartum.
“The incidence of TD during pregnancy in women with TD is threefold higher than in the general population, particularly in the first trimester of pregnancy and in the first year postpartum ().”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationSubclinical hypothyroidism was associated with albuminuria in patients with type 2 diabetes, and increased serum TSH was an independent risk factor for albuminuria.
“SHypo was associated with albuminuria in patients with TD, and an increased serum TSH was an independent risk factor for the presence of albuminuria ().”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationIndividual participant data meta-analyses reported that subclinical hypothyroidism was associated with increased risk for coronary heart disease events and mortality and heart failure, especially in patients with serum TSH >10 mU/L.
“Individual participant data meta-analyses reported that SHypo was associated with an increased risk for coronary heart disease (CHD) events and mortality () and heart failure (), especially in patients with serum TSH .mU/L.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationThe clinical presentation of postpartum thyroiditis can vary from hyperthyroidism to hypothyroidism or both and is associated with a significantly increased incidence of depression.
“The clinical presentation can vary from hyperthyroidism to hypothyroidism or both and is associated with a significant increased incidence of depression ().”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationA large meta-analysis reported that thyroid autoantibodies did not increase the risk of gestational diabetes in euthyroid pregnant women, and their positivity in the first trimester did not predict gestational diabetes risk.
“A large meta-analysis reported that the presence of thyroid autoantibodies did not increase the risk of GDM in euthyroid pregnant women, and their positivity in the first trimester did not have a predictive value for the risk of GDM ().”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationPatients with diabetes have increased risk of heart disease, stroke, heart failure, kidney disease, blindness, amputations, and neuropathy.
“Patients with DM have an increased risk of heart disease, stroke, heart failure, kidney disease, blindness, amputations, and neuropathy (-).”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningThe reviewed studies suggest that atherogenic dyslipidemia, insulin resistance, and hypertension can be linked with overt and subclinical hypothyroid states, and thyroid hormone deficiency is significantly associated with some components of metabolic syndrome.
“All of these studies suggest that atherogenic dyslipidemia, insulin resistance, and hypertension can be linked with overt and subclinical hypothyroid states, and consequently TH deficiency is significantly associated with some components of MetS.”
Quote in the paperSubstantial claimMay combine two claims.
Premisenone givenPoor metabolic control, which is more common when TD develops, can mask the clinical symptoms of TD.
“clinical symptoms of TD may be masked by a poor metabolic control, which is more frequent when TD develops”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationEuthyroid subjects with TSH in the upper normal range (2.5-4.5 mU/L) were more obese (BMI >30), had higher triglyceride levels, and had increased likelihood of metabolic syndrome.
“Euthyroid subjects with TSH values in the upper normal range (. to . mU/L) were more obese (BMI .kg/m ), had higher triglyceride levels, and had an increased likelihood of having MetS ().”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationSubclinical hypothyroidism was associated with an odds ratio of 3.15 (95% CI 1.48-6.69) for development of diabetic nephropathy and was also responsible for increased risk of cardiovascular events mediated by diabetic nephropathy.
“SHypo was associated with an OR of . (% CI, . to .) for the development of DN and was also responsible for an increased risk of cardiovascular events mediated by DN ().”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationMild subclinical thyroid disease progresses slowly, at roughly 1% over five years, which suggests a need for long-term screening.
“Mild subclinical thyroid disease can progress at a low rate, suggesting a long-term screening program.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [3] Hollowell, 2002, Serum TSH, T4, and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III), J Clin Endocrinol Metab source
Not checked in the free run.
- cites [4] Cooper, 2012, Subclinical thyroid disease, Lancet source
Not checked in the free run.
May combine two claims.
Premisenone givenUnrecognized thyroid disorders can worsen metabolic control and increase cardiovascular risk in T2D patients.
“Undetected thyroid disorders can compromise the metabolic control and amplify the risk of cardiovascular events.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
InterpretationreasoningBecause of these uncertainties, specific recommendations from major endocrine and diabetes society guidelines cannot be adopted.
“These uncertainties do not allow us to adopt specific recommendations from the guidelines published by the major endocrine and diabetes societies”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
InterpretationreasoningTD screening might prevent the serious cardiovascular complications associated with T2D.
“The screening of TD could prevent the high cardiovascular complications of T2D.”
Quote in the paperSubstantial claim
The paper relies on this without support.
Insulin resistance is the main clinical and pathogenic feature of metabolic syndrome.
“Isulin resistance is the main clinical and pathogenic feature of this syndrome.”
The paper relies on this without support.
Human brown adipose tissue is more important in neonates than in adults.
“However, human BAT is considered more important in neonates than in the adults.”
The paper relies on this without support.
The prevalence of hypothyroidism in women of reproductive age is 2% to 3%.
“The prevalence of hypothyroidism in women during the reproductive age is % to %, and chronic autoimmune thyroiditis is the main cause of hypothyroidism during pregnancy.”
The paper relies on this without support.
Postpartum thyroiditis is caused by destructive autoimmune thyroiditis in the postpartum period, mediated by a rebound of cellular and humoral immunity.
“Postpartum thyroiditis (PPTD) is caused by a destructive autoimmune thyroiditis in the postpartum period, mediated by a rebound of both cellular and humoral immunity.”
The paper relies on this without support.
The cost-benefit ratio is favorable for screening thyroid dysfunction in type 1 diabetes.
“• The cost-benefit ratio is favorable for a screening of TD.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Excess T3 leads to considerable impairment of islet function.
“Furthermore, excess T3 leads to considerable impairment of the islet function, while physiological T3 treatment promotes beta-cell proliferation (57, 62).”
From The progression of secondary diabetes: A review of modeling studies (2022) · cites this paper as [57]
The section on central and peripheral thyroid-hormone effects states that hyperthyroidism and high-fat feeding significantly impair islet function. The paper also says thyroid-hormone excess increases beta-cell apoptosis, but it does not clearly attribute the reported islet impairment to excess T3 alone; the claim omits the high-fat-feeding condition. (LLM, conf=0.83)
Experimental — accuracy not yet measuredChanges in serum TSH are associated with the incidence of T2DM, but the connection is merely significant in hypothyroidism.
“Changes in serum TSH are also associated with the incidence of T2DM, but the connection is merely significant in hypothyroidism (57).”
From The progression of secondary diabetes: A review of modeling studies (2022) · cites this paper as [57]
The Hypothyroidism and T2D section says prospective studies investigated whether changes in serum TSH or thyroid hormones were associated with diabetes risk. It does not establish that the association is significant only in hypothyroidism. The Underlying Mechanisms section also reports an increased diabetes risk in one study of people with hyperthyroidism, while noting conflicting results across studies; page numbers were not available in the indexed passages. (LLM, conf=0.77)
Experimental — accuracy not yet measuredThyroid dysfunction and diabetes mellitus are closely linked, and the liver is the main organ of glucose metabolism in the human.
“Thyroid dysfunction and diabetes mellitus are closely linked, and the liver is the main organ of glucose metabolism in the human (Biondi et al., 2019; Sridhar et al., 2014).”
From Exposure to per- and polyfluoroalkyl substances in early pregnancy, risk of gestational diabetes mellitus, potential pathways, and influencing factors in pregnant women: A nested case-control study (2023) · cites this paper as Biondi et al., 2019
The Abstract explicitly states that thyroid dysfunction and diabetes mellitus are closely linked. The section on hepatic glucose production describes the liver’s role in glucose regulation, but does not establish that it is the main organ of glucose metabolism in humans. (LLM, conf=0.87)
Experimental — accuracy not yet measuredT3 exerts profound effects on the proliferation of pancreatic islet cells and insulin secretion.
“Moreover, T3 exerts profound effects on the proliferation of pancreatic islet cells and insulin secretion (57, 59).”
From The progression of secondary diabetes: A review of modeling studies (2022) · cites this paper as [57]
Diabetes mellitus is strongly associated with thyroid dysfunction.
“There are strong associations between diabetes mellitus and numerous concurrent health issues, such as osteoporosis, thyroid dysfunction, and abnormalities in iron metabolism (2–4).”
From Biological variation in serum thyroid, iron metabolism, and plasma bone metabolism biomarkers in patients with type 2 diabetes mellitus (2025) · cites this paper as [2]
Diabetes mellitus is strongly associated with abnormalities in iron metabolism.
“There are strong associations between diabetes mellitus and numerous concurrent health issues, such as osteoporosis, thyroid dysfunction, and abnormalities in iron metabolism (2–4).”
From Biological variation in serum thyroid, iron metabolism, and plasma bone metabolism biomarkers in patients with type 2 diabetes mellitus (2025) · cites this paper as [2]
Physiological T3 treatment promotes beta-cell proliferation.
“Furthermore, excess T3 leads to considerable impairment of the islet function, while physiological T3 treatment promotes beta-cell proliferation (57, 62).”
From The progression of secondary diabetes: A review of modeling studies (2022) · cites this paper as [57]
Diabetes mellitus is strongly associated with osteoporosis.
“There are strong associations between diabetes mellitus and numerous concurrent health issues, such as osteoporosis, thyroid dysfunction, and abnormalities in iron metabolism (2–4).”
From Biological variation in serum thyroid, iron metabolism, and plasma bone metabolism biomarkers in patients with type 2 diabetes mellitus (2025) · cites this paper as [2]
The passage under “Underlying Mechanisms of the Association Between TD and Type 2 DM” supports an association between diabetes and thyroid dysfunction, but it does not address osteoporosis. A search of our copy for a diabetes–osteoporosis association found no supporting passage, so the specific claim in the quote cannot be verified from this source. (LLM, conf=0.75)
Experimental — accuracy not yet measured
Cites
Grundy, S. M., Cleeman, J. I., Daniels, S. R., Donato, K. A., Eckel, R. H., Franklin, B. A., Gordon, D. J., Krauss, R. M., Savage, P. J., Smith, S. C., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.169404 · Cited by 11,961 · see citing works
Standards of Medical Care in Diabetes
Power, D. V. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1593 · Cited by 8,672 · see citing works
Haffner, S. M., Lehto, S., Rönnemaa, T., Pyörälä, K., & Laakso, M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807233390404 · Cited by 7,000 · see citing works
Eckel, R. H., Alberti, K., Grundy, S. M., & Zimmet, P. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61794-3 · Cited by 6,283 · see citing works
Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001
Mokdad, A. H., Ford, E. S., Bowman, B. A., Dietz, W. H., Vinicor, F., Bales, V. S., & Marks, J. S. (2003) · JAMA · doi:10.1001/jama.289.1.76 · Cited by 5,866 · see citing works
Eckel, R. H., Grundy, S. M., & Zimmet, P. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66378-7 · Cited by 5,566 · see citing works
The National Center for Biotechnology Information
Benson, D. A., Boguski, M. S., Lipman, D. J., & Ostell, J. (1990) · Genomics · doi:10.1016/0888-7543(90)90583-g · Cited by 5,109 · see citing works
Global estimates of diabetes prevalence for 2013 and projections for 2035
Guariguata, L., Whiting, D. R., Hambleton, I., Beagley, J., Linnenkamp, U., & Shaw, J. E. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.11.002 · Cited by 4,642 · see citing works
Identification and Importance of Brown Adipose Tissue in Adult Humans
Cypess, A. M., Lehman, S., Williams, G., Tal, I., Rodman, D., Goldfine, A. B., Kuo, F. C., Palmer, E. L., Tseng, Y.-H., Doria, A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810780 · Cited by 4,399 · see citing works
Hollowell, J. G., Staehling, N. W., Flanders, W. D., Hannon, W. H., Gunter, E. W., Spencer, C. A., & Braverman, L. E. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.2.489 · Cited by 4,279 · see citing works
Stamler, J., Vaccaro, O., Neaton, J. D., Wentworth, D., & The Multiple Risk Factor Intervention Trial Research Group (1993) · Diabetes Care · doi:10.2337/diacare.16.2.434 · Cited by 4,063 · see citing works
Cold-Activated Brown Adipose Tissue in Healthy Men
van Marken Lichtenbelt, W. D., Vanhommerig, J. W., Smulders, N. M., Drossaerts, J. M. A. F. L., Kemerink, G. J., Bouvy, N. D., Schrauwen, P., & Teule, G. J. J. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808718 · Cited by 3,452 · see citing works
Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis
Bellamy, L., Casas, J.-P., Hingorani, A. D., & Williams, D. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60731-5 · Cited by 3,253 · see citing works
2. Classification and Diagnosis of Diabetes: <i>Standards of Medical Care in Diabetes—2018</i>
American Diabetes Association (2018) · Diabetes Care · doi:10.2337/dc18-s002 · Cited by 3,159 · see citing works
Prevalence of Diabetes among Men and Women in China
Yang, W., Lu, J., Weng, J., Jia, W., Ji, L., Xiao, J., Shan, Z., Liu, J., Tian, H., Ji, Q., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0908292 · Cited by 3,031 · see citing works
Stagnaro-Green, A., Abalovich, M., Alexander, E., Azizi, F., Mestman, J., Negro, R., Nixon, A., Pearce, E. N., Soldin, O. P., Sullivan, S., et al. (2011) · Thyroid · doi:10.1089/thy.2011.0087 · Cited by 2,942 · see citing works
Ross, D. S., Burch, H. B., Cooper, D. S., Greenlee, M. C., Laurberg, P., Maia, A. L., Rivkees, S. A., Samuels, M., Sosa, J. A., Stan, M. N., et al. (2016) · Thyroid® · doi:10.1089/thy.2016.0229 · Cited by 2,938 · see citing works
The Colorado Thyroid Disease Prevalence Study
Canaris, G. J., Manowitz, N. R., Mayor, G., & Ridgway, E. C. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.4.526 · Cited by 2,824 · see citing works
Alexander, E. K., Pearce, E. N., Brent, G. A., Brown, R. S., Chen, H., Dosiou, C., Grobman, W. A., Laurberg, P., Lazarus, J. H., Mandel, S. J., et al. (2017) · Thyroid® · doi:10.1089/thy.2016.0457 · Cited by 2,731 · see citing works
Diabetes Mellitus, Fasting Glucose, and Risk of Cause-Specific Death
The Emerging Risk Factors Collaboration (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1008862 · Cited by 2,726 · see citing works
THE SPECTRUM OF THYROID DISEASE IN A COMMUNITY: THE WHICKHAM SURVEY
Tunbridge, W. M. G., Evered, D. C., Hall, R., Appleton, D. R., BREWIS, M., CLARK, F., Evans, J. G., Young, E. T., Bird, T., & Smith, P. (1977) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1977.tb01340.x · Cited by 2,665 · see citing works
Statins and risk of incident diabetes: A collaborative meta-analysis of randomised statin trials
Sattar, N., Preiss, D., Murray, H. M., Welsh, P., Buckley, B. M., de Craen, A. J., Seshasai, S. R. K., McMurray, J. J., Freeman, D. J., Jukema, J. W., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61965-6 · Cited by 2,436 · see citing works
Thyroid Hormone Regulation of Metabolism
Mullur, R., Liu, Y.-Y., & Brent, G. A. (2014) · Physiological Reviews · doi:10.1152/physrev.00030.2013 · Cited by 2,421 · see citing works
Prevalence of and Trends in Diabetes Among Adults in the United States, 1988-2012
Menke, A., Casagrande, S., Geiss, L., & Cowie, C. C. (2015) · JAMA · doi:10.1001/jama.2015.10029 · Cited by 2,362 · see citing works
Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus
Cowley, M. A., Smart, J. L., Rubinstein, M., Cerdán, M. G., Diano, S., Horvath, T. L., Cone, R. D., & Low, M. J. (2001) · Nature · doi:10.1038/35078085 · Cited by 2,356 · see citing works
Gestational Diabetes and the Incidence of Type 2 Diabetes
Kim, C., Newton, K. M., & Knopp, R. H. (2002) · Diabetes Care · doi:10.2337/diacare.25.10.1862 · Cited by 2,276 · see citing works
Wilson, A. G., Symons, J. A., McDowell, T. L., McDevitt, H. O., & Duff, G. W. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.7.3195 · Cited by 2,217 · see citing works
The biology of incretin hormones
Drucker, D. J. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.01.004 · Cited by 2,210 · see citing works
Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease
Ueda, H., Howson, J. M. M., Esposito, L., Heward, J., Snook, Chamberlain, G., Rainbow, D. B., Hunter, K. M. D., Smith, A. N., Di Genova, G., et al. (2003) · Nature · doi:10.1038/nature01621 · Cited by 2,175 · see citing works
Standards of Medical Care in Diabetes—2009
American Diabetes Association (2009) · Diabetes Care · doi:10.2337/dc09-s013 · Cited by 2,167 · see citing works
Cornier, M.-A., Dabelea, D., Hernandez, T. L., Lindstrom, R. C., Steig, A. J., Stob, N. R., Van Pelt, R. E., Wang, H., & Eckel, R. H. (2008) · Endocrine Reviews · doi:10.1210/er.2008-0024 · Cited by 2,162 · see citing works
Jonklaas, J., Bianco, A. C., Bauer, A. J., Burman, K. D., Cappola, A. R., Celi, F. S., Cooper, D. S., Kim, B. W., Peeters, R. P., Rosenthal, M. S., et al. (2014) · Thyroid® · doi:10.1089/thy.2014.0028 · Cited by 1,928 · see citing works
DeGroot, L. J., Abalovich, M., Alexander, E. K., Amino, N., Barbour, L. A., Cobin, R. H., Eastman, C. J., Lazarus, J. H., Luton, D., Mandel, S. J., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2803 · Cited by 1,862 · see citing works
Malik, S., Wong, N. D., Franklin, S. S., Kamath, T. V., L'Italien, G. J., Pio, J. R., & Williams, G. R. (2004) · Circulation · doi:10.1161/01.cir.0000140677.20606.0e · Cited by 1,845 · see citing works
Yki-Järvinen, H. (2004) · New England Journal of Medicine · doi:10.1056/nejmra041001 · Cited by 1,830 · see citing works
Changes in diabetes-related complications in the United States, 1990-2010
Gregg, E. W., Li, Y., Wang, J., Rios Burrows, N., Ali, M. K., Rolka, D., Williams, D. E., & Geiss, L. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1310799 · Cited by 1,749 · see citing works
Garber, J. R., Cobin, R. H., Gharib, H., Hennessey, J. V., Klein, I., Mechanick, J. I., Pessah-Pollack, R., Singer, P. A., & Woeber, K. A. (2012) · Endocrine Practice · doi:10.4158/ep12280.gl · Cited by 1,567 · see citing works
A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes
Bottini, N., Musumeci, L., Alonso, A., Rahmouni, S., Nika, K., Rostamkhani, M., MacMurray, J. P., Meloni, T., Lucarelli, P., Pellecchia, M., et al. (2004) · Nature Genetics · doi:10.1038/ng1323 · Cited by 1,419 · see citing works
The Clinical Significance of Subclinical Thyroid Dysfunction
Biondi, B., & Cooper, D. S. (2008) · Endocrine Reviews · doi:10.1210/er.2006-0043 · Cited by 1,418 · see citing works
Self-citationStandards of Medical Care in Diabetes—2008
Dora, J. M., Kramer, C. K., & Canani, L. H. S. (2008) · Diabetes Care · doi:10.2337/dc08-0109 · Cited by 1,413 · see citing works
Standards of Medical Care in Diabetes—2008
American Diabetes Association (2008) · Diabetes Care · doi:10.2337/dc08-s012 · Cited by 1,377 · see citing works
Retinol-Binding Protein 4 and Insulin Resistance in Lean, Obese, and Diabetic Subjects
Graham, T. E., Yang, Q., Blüher, M., Hammarstedt, A., Ciaraldi, T. P., Henry, R. R., Wason, C. J., Oberbach, A., Jansson, P.-A., Smith, U., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054862 · Cited by 1,319 · see citing works
Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome.
Ehrmann, D. A., Barnes, R. B., Rosenfield, R. L., Cavaghan, M. K., & Imperial, J. (1999) · Diabetes Care · doi:10.2337/diacare.22.1.141 · Cited by 1,257 · see citing works
Mechanisms of thyroid hormone action
Brent, G. A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci60047 · Cited by 1,244 · see citing works
Grundy, S. M. (2010) · Springer eBooks · doi:10.1007/978-1-4419-5839-6_1 · Cited by 1,225 · see citing works
Subclinical Hypothyroidism and the Risk of Coronary Heart Disease and Mortality
Rodondi, N., den Elzen, W. P. J., Bauer, D. C., Cappola, A. R., Razvi, S., Walsh, J. P., Åsvold, B. O., Iervasi, G., Imaizumi, M., Collet, T.-H., et al. (2010) · JAMA · doi:10.1001/jama.2010.1361 · Cited by 1,216 · see citing works
Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young
Fajans, S. S., Bell, G. I., & Polonsky, K. S. (2001) · New England Journal of Medicine · doi:10.1056/nejmra002168 · Cited by 1,123 · see citing works
Chronic intracerebroventricular infusion of insulin reduces food intake and body weight of baboons
Woods, S. C., Lotter, E. C., McKay, L. D., & Porte, D. (1979) · Nature · doi:10.1038/282503a0 · Cited by 1,114 · see citing works
Garber, J. R., Cobin, R. H., Gharib, H., Hennessey, J. V., Klein, I., Mechanick, J. I., Pessah-Pollack, R., Singer, P. A., & Woeber for the American Association, K. A. (2012) · Thyroid · doi:10.1089/thy.2012.0205 · Cited by 1,053 · see citing works
Cooper, D. S., & Biondi, B. (2012) · The Lancet · doi:10.1016/s0140-6736(11)60276-6 · Cited by 1,039 · see citing works
Self-citationStratton, I. M., Kohner, E. M., Aldington, S. J., Turner, R. C., Holman, R. R., Manley, S. E., & Matthews, D. R. (2001) · Diabetologia · doi:10.1007/s001250051594 · Cited by 1,019 · see citing works
Excess Mortality among Persons with Type 2 Diabetes
Tancredi, M., Rosengren, A., Svensson, A., Kosiborod, M., Pivodic, A., Guðbjörnsdóttir, S., Wedel, H., Clements, M. A., Dahlqvist, S., & Lind, M. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1504347 · Cited by 996 · see citing works
Glycemic Control and Excess Mortality in Type 1 Diabetes
Lind, M., Svensson, A.-M., Kosiborod, M., Gudbjörnsdottir, S., Pivodic, A., Wedel, H., Dahlqvist, S., Clements, M., & Rosengren, A. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1408214 · Cited by 964 · see citing works
Brain-derived neurotrophic factor regulates energy balance downstream of melanocortin-4 receptor
Xu, B., Goulding, E. H., Zang, K., Cepoi, D., Cone, R. D., Jones, K. R., Tecott, L. H., & Reichardt, L. F. (2003) · Nature Neuroscience · doi:10.1038/nn1073 · Cited by 896 · see citing works
Cellular and Molecular Basis of Deiodinase-Regulated Thyroid Hormone Signaling1
Gereben, B., Zavacki, A. M., Ribich, S., Kim, B. W., Huang, S. A., Simonides, W. S., Zeöld, A., & Bianco, A. C. (2008) · Endocrine Reviews · doi:10.1210/er.2008-0019 · Cited by 891 · see citing works
2013 ETA Guideline: Management of Subclinical Hypothyroidism
Pearce, S. H. S., Brabant, G., Duntas, L. H., Monzani, F., Peeters, R. P., Razvi, S., & Wemeau, J.-L. (2013) · European Thyroid Journal · doi:10.1159/000356507 · Cited by 877 · see citing works
Ratner, R. E., Christophi, C. A., Metzger, B. E., Dabelea, D., Bennett, P. H., Pi-Sunyer, X., Fowler, S., Kahn, S. E., & The Diabetes Prevention Program Research Group (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0772 · Cited by 867 · see citing works
Leptin Activates Hypothalamic CART Neurons Projecting to the Spinal Cord
Elias, C. F., Lee, C., Kelly, J., Aschkenasi, C. J., Ahima, R. S., Couceyro, P. R., Kuhar, M. J., Saper, C. B., & Elmquist, J. K. (1998) · Neuron · doi:10.1016/s0896-6273(00)80656-x · Cited by 809 · see citing works
Broberger, C., Johansen, J., Johansson, C., Schalling, M., & Hökfelt, T. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.15043 · Cited by 798 · see citing works
Knudsen, N., Laurberg, P., Rasmussen, L. B., Bülow, I., Perrild, H., Ovesen, L., & Jørgensen, T. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2225 · Cited by 753 · see citing works
Lazarus, J., Brown, R. S., Daumerie, C., Hubalewska-Dydejczyk, A., Negro, R., & Vaidya, B. (2014) · European Thyroid Journal · doi:10.1159/000362597 · Cited by 742 · see citing works
Duntas, L. H. (2002) · Thyroid · doi:10.1089/10507250252949405 · Cited by 725 · see citing works
Decreasing hypothalamic insulin receptors causes hyperphagia and insulin resistance in rats
Obici, S., Feng, Z., Karkanias, G., Baskin, D. G., & Rossetti, L. (2002) · Nature Neuroscience · doi:10.1038/nn0602-861 · Cited by 719 · see citing works
Barr, E. L. M., Zimmet, P. Z., Welborn, T. A., Jolley, D., Magliano, D. J., Dunstan, D. W., Cameron, A. J., Dwyer, T., Taylor, H. R., Tonkin, A. M., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.685628 · Cited by 719 · see citing works
Hypothalamic AMPK and fatty acid metabolism mediate thyroid regulation of energy balance
López, M., Varela, L., Vazquez, M. J., Rodríguez‐Cuenca, S., González, C. R., Velagapudi, V., Morgan, D. A., Schoenmakers, E., Agassandian, K., Lage, R., et al. (2010) · Nature Medicine · doi:10.1038/nm.2207 · Cited by 682 · see citing works
Baskin, H. J., Cobin, R. H., Duick, D. S., Gharib, H., Guttler, R. B., Kaplan, M. M., Segal, R. L., Garber, J. R., Hamilton Jr, C. R., Handelsman, Y., et al. (2002) · Endocrine Practice · doi:10.4158/1934-2403-8.6.457 · Cited by 673 · see citing works
Bjerre Knudsen, L., Madsen, L. W., Andersen, S., Almholt, K., de Boer, A. S., Drucker, D. J., Gotfredsen, C., Egerod, F. L., Hegelund, A. C., Jacobsen, H., et al. (2010) · Endocrinology · doi:10.1210/en.2009-1272 · Cited by 672 · see citing works
Autoimmune Polyendocrine Syndromes
Eisenbarth, G. S., & Gottlieb, P. A. (2004) · New England Journal of Medicine · doi:10.1056/nejmra030158 · Cited by 664 · see citing works
American Thyroid Association guidelines for detection of thyroid dysfunction.
Ladenson, P., Singer, P., Ain, K., Bagchi, N., Bigos, S., Levy, E., Smith, S. A., Daniels, G., & Cohen, H. D. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.11.1573 · Cited by 658 · see citing works
Louis, E. J., Franchimont, D. P., Piron, A., Gevaert, Y., Schaaf‐Lafontaine, N., Roland, S., Mahieu, P. R., Malaise, M., Groote, D. D., Louis, R. E., et al. (1998) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.1998.00662.x · Cited by 575 · see citing works
Decreasing hypothalamic insulin receptors causes hyperphagia and insulin resistance in rats
Obici, S., Feng, Z., Karkanias, G. B., et al. (2002) · Nature Neuroscience · doi:10.1038/nn861 · Cited by 572 · see citing works
How Obesity Causes Diabetes: Not a Tall Tale
Lazar, M. A. (2005) · Science · doi:10.1126/science.1104342 · Cited by 570 · see citing works
Thyroid Function Is Associated with Components of the Metabolic Syndrome in Euthyroid Subjects
Roos, A., Bakker, S. J. L., Links, T. P., Gans, R. O. B., & Wolffenbuttel, B. H. R. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1718 · Cited by 542 · see citing works
A MOLECULAR PERSPECTIVE OF CTLA-4 FUNCTION
Teft, W. A., Kirchhof, M. G., & Madrenas, J. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.24.021605.090535 · Cited by 518 · see citing works
Gencer, B., Collet, T.-H., Virgini, V., Bauer, D. C., Gussekloo, J., Cappola, A. R., Nanchen, D., den Elzen, W. P. J., Balmer, P., Luben, R. N., et al. (2012) · Circulation · doi:10.1161/circulationaha.112.096024 · Cited by 517 · see citing works
Myeloid C-type lectins in innate immunity
Robinson, M. J., Sancho, D., Slack, E. M. C., LeibundGut‐Landmann, S., & Sousa, C. R. E. (2006) · Nature Immunology · doi:10.1038/ni1417 · Cited by 511 · see citing works
Smyth, D. J., Cooper, J. D., Collins, J. E., Heward, J. M., Franklyn, J. A., Howson, J. M. M., Vella, A. V., Nutland, S. L., Rance, H. E., Maier, L. M., et al. (2004) · Diabetes · doi:10.2337/diabetes.53.11.3020 · Cited by 504 · see citing works
Zarjevski, N., Cusin, I., Vettor, R., Rohner‐Jeanrenaud, F., & Jeanrenaud, B. (1993) · Endocrinology · doi:10.1210/endo.133.4.8404618 · Cited by 476 · see citing works
Autoimmune Polyglandular Syndromes
Neufeld, M., Maclaren, N. K., & Blizzard, R. M. (1980) · Pediatric Annals · doi:10.3928/0090-4481-19800401-07 · Cited by 471 · see citing works
Velaga, M., Wilson, V., Jennings, C., Owen, C. J., Herington, S. D., Donaldson, P. T., Ball, S. G., James, R. A., Quinton, R., Perros, P., et al. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1108 · Cited by 464 · see citing works
Studies of insulin resistance in patients with clinical and subclinical hypothyroidism
Maratou, E., Hadjidakis, D., Κόλλιας, Α., TSEGKA, K. G., Peppa, Μ., Alevizaki, M., Mitrou, P., Lambadiari, V., Boutati, E. I., Nikzas, D., et al. (2009) · European Journal of Endocrinology · doi:10.1530/eje-08-0797 · Cited by 459 · see citing works
Type 2 Diabetes as a “Coronary Heart Disease Equivalent”
Juutilainen, A., Lehto, S., Rönnemaa, T., Pyörälä, K., & Laakso, M. (2005) · Diabetes Care · doi:10.2337/diacare.28.12.2901 · Cited by 452 · see citing works
Frequency of Thyroid Dysfunction in Diabetic Patients: Value of Annual Screening
Perros, P., McCrimmon, R. J., Shaw, G., & Frier, B. M. (1995) · Diabetic Medicine · doi:10.1111/j.1464-5491.1995.tb00553.x · Cited by 441 · see citing works
Palmer, S. C., Mavridis, D., Nicolucci, A., Johnson, D. W., Tonelli, M. A., Craig, J. C., Maggo, J. K., Gray, V., Berardis, G. D., Ruospo, M., et al. (2016) · JAMA · doi:10.1001/jama.2016.9400 · Cited by 423 · see citing works
Cloutier, J., & Veillette, A. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.1.111 · Cited by 422 · see citing works
CTLA-4-Mediated Inhibition of Early Events of T Cell Proliferation
Brunner-Weinzierl, M. C., Chambers, C. A., Chan, F. K.-M., Hanke, J., Winoto, A., & Allison, J. P. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.10.5813 · Cited by 419 · see citing works
Łabuzek, K., Suchy, D., Gabryel, B., Bielecka, A., Liber, S., & Okopień, B. (2010) · Pharmacological Reports · doi:10.1016/s1734-1140(10)70357-1 · Cited by 404 · see citing works
CTLA4 Alanine-17 Confers Genetic Susceptibility to Graves’ Disease and to Type 1 Diabetes Mellitus1
Donner, H., Rau, H., Walfish, P. G., Braun, J., Siegmund, T., Finke, R., Herwig, J., Usadel, K. H., & Badenhoop, K. W. J. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.1.3699 · Cited by 396 · see citing works
Insulin Resistance and Type 2 Diabetes
Taylor, R. (2012) · Diabetes · doi:10.2337/db12-0073 · Cited by 394 · see citing works
Prevalence of Diabetes and Impaired Fasting Glucose in the Adult Population of Iran
Esteghamati, A., Gouya, M. M., Abbasi, M., Delavari, A., Alikhani, S., Alaedini, F., Safaie, A., Forouzanfar, M. H., & Gregg, E. W. (2007) · Diabetes Care · doi:10.2337/dc07-0959 · Cited by 384 · see citing works
Thyroid Hormone as a Determinant of Energy Expenditure and the Basal Metabolic Rate
Kim, B. W. (2008) · Thyroid · doi:10.1089/thy.2007.0266 · Cited by 383 · see citing works
Cohen, S., Dadi, H., Shaoul, E., Sharfe, N., & Roifman, C. M. (1999) · Blood · doi:10.1182/blood.v93.6.2013.406k25_2013_2024 · Cited by 381 · see citing works
Polyglandular Autoimmune Syndromes: Immunogenetics and Long-Term Follow-Up
Dittmar, M., & Kahaly, G. J. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021845 · Cited by 367 · see citing works
Self-citationType 2 iodothyronine deiodinase is the major source of plasma T3 in euthyroid humans
Luiza Maia, A. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25083 · Cited by 360 · see citing works
Biondi, B. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.12.4701 · Cited by 356 · see citing works
Self-citationThyroid Hormone Regulation of Hepatic Genes in Vivo Detected by Complementary DNA Microarray
Feng, X., Jiang, Y. Y., Meltzer, P. S., & Yen, P. M. (2000) · Molecular Endocrinology · doi:10.1210/mend.14.7.0470 · Cited by 354 · see citing works
Role of PTPN22 in type 1 diabetes and other autoimmune diseases
Bottini, N., Vang, T., Cucca, F., & Mustelin, T. (2006) · Seminars in Immunology · doi:10.1016/j.smim.2006.03.008 · Cited by 350 · see citing works
Åsvold, B. O., Vatten, L. J., Nilsen, T. I. L., & Bjøro, T. (2007) · European Journal of Endocrinology · doi:10.1530/eje.1.02333 · Cited by 350 · see citing works
Carotid Atherosclerosis and Coronary Heart Disease in the Metabolic Syndrome
Bonora, E., Kiechl, S. J., Willeit, J., Oberhollenzer, F., Egger, G., Bonadonna, R. C., & Muggeo, M. (2003) · Diabetes Care · doi:10.2337/diacare.26.4.1251 · Cited by 332 · see citing works
Thyroid and Obesity: An Intriguing Relationship
Biondi, B. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1245 · Cited by 330 · see citing works
Self-citationChanges in Diabetes-Related Complications in the United States
Gregg, E. W., Williams, D. E., & Geiss, L. (2014) · New England Journal of Medicine · doi:10.1056/nejmc1406009 · Cited by 327 · see citing works
Biondi, B., Bartalena, L., Cooper, D. S., Hegedüs, L., Laurberg, P., & Kahaly, G. J. (2015) · European Thyroid Journal · doi:10.1159/000438750 · Cited by 323 · see citing works
Self-citationCharacteristics of BDNF-induced weight loss
Pelleymounter, M. A., Cullen, M. J., & Wellman, C. L. (1995) · Experimental Neurology · doi:10.1016/0014-4886(95)90045-4 · Cited by 321 · see citing works
Thyroid Autoimmunity in Children and Adolescents With Type 1 Diabetes
Kordonouri, O., Klinghammer, A., Lang, E. B., Grüters‐Kieslich, A., Grabert, M., Holl, R. W., & On behalf of the DPV-Initiative of the German Working Group for Pediatric Diabetology (2002) · Diabetes Care · doi:10.2337/diacare.25.8.1346 · Cited by 311 · see citing works
Fox, C. S. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.6.587 · Cited by 303 · see citing works
Heart failure: a cardiovascular outcome in diabetes that can no longer be ignored
McMurray, J. J. V., Gerstein, H. C., Holman, R. R., & Pfeffer, M. A. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(14)70031-2 · Cited by 303 · see citing works
Thyroid hormone stimulates hepatic lipid catabolism via activation of autophagy
Sinha, R. A., You, S.-H., Zhou, J., Siddique, M. M., Bay, B.-H., Zhu, X., Privalsky, M. L., Cheng, S.-Y., Stevens, R. D., Summers, S. A., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci60580 · Cited by 303 · see citing works
Karakosta, P., Alegakis, D., Georgiou, V., Roumeliotaki, T., Fthenou, E., Vassilaki, M. E., Boumpas, D., Castanas, E., Kogevinas, M., & Chatzi, L. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2540 · Cited by 299 · see citing works
Coppola, A., Liu, Z.-W., Andrews, Z. B., Paradis, E., Roy, M.-C., Friedman, J. M., Ricquier, D., Richard, D., Horvath, T. L., Gao, X.-B., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2006.12.002 · Cited by 295 · see citing works
Thyroid Function in Humans with Morbid Obesity
Michalaki, M. A., Vagenakis, A. G., Leonardou, A., Argentou, M. N., Habeos, I. G., Makri, M. G., Psyrogiannis, A. I., Kalfarentzos, F. E., & Kyriazopoulou, V. E. (2006) · Thyroid · doi:10.1089/thy.2006.16.73 · Cited by 295 · see citing works
Anjos, S. M., Nguyen, A., Ounissi‐Benkalha, H., Tessier, M.-C., & Polychronakos, C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206894200 · Cited by 295 · see citing works
Biondi, B., & Cooper, D. S. (2010) · Thyroid · doi:10.1089/thy.2009.0311 · Cited by 286 · see citing works
Self-citationCTLA4 Alanine-17 Confers Genetic Susceptibility to Graves' Disease and to Type 1 Diabetes Mellitus
Donner, H. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.1.143 · Cited by 286 · see citing works
The relationship between type 2 diabetes mellitus and related thyroid diseases
Wang, C. (2013) · Journal of Diabetes Research · doi:10.1155/2013/390534 · Cited by 273 · see citing works
Update in Lipid Alterations in Subclinical Hypothyroidism
Pearce, E. N. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2532 · Cited by 272 · see citing works
Ribeiro, M. O., Carvalho, S. D., Schultz, J. J., Chiellini, G., Scanlan, T. S., Bianco, A. C., & Brent, G. A. (2001) · Journal of Clinical Investigation · doi:10.1172/jci200112584 · Cited by 271 · see citing works
Garduño-Garcia, J. D. J., Alvirde-Garcia, U., López-Carrasco, G., Padilla Mendoza, M. E., Mehta, R., Arellano-Campos, O., Choza, R., Sauque, L., Garay-Sevilla, M. E., Malacara, J. M., et al. (2010) · European Journal of Endocrinology · doi:10.1530/eje-10-0312 · Cited by 268 · see citing works
Shin, D.-J., & Osborne, T. F. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305417200 · Cited by 266 · see citing works
Treatment with thyroid hormone
Biondi, B., & Wartofsky, L. (2014) · Endocrine Reviews · doi:10.1210/er.2013-1083 · Cited by 259 · see citing works
Self-citationSubclinical hypothyroidism and type 2 diabetes: A systematic review and meta-analysis
Han, C., He, X., Xia, X., Li, Y., Shi, X., Shan, Z., & Teng, W. (2015) · PLoS ONE · doi:10.1371/journal.pone.0135233 · Cited by 258 · see citing works
Thyroid Hormones and the Metabolic Syndrome
Iwen, K. A., Schröder, E., & Brabant, G. E. (2013) · European Thyroid Journal · doi:10.1159/000351249 · Cited by 253 · see citing works
Ortiz‐Lopez, C., Lomonaco, R., Orsak, B., Finch, J., Chang, Z., Kochunov, V., Hardies, J., & Cusi, K. J. (2012) · Diabetes Care · doi:10.2337/dc11-1849 · Cited by 253 · see citing works
Polyglandular autoimmune syndromes
Kahaly, G. J. (2009) · European Journal of Endocrinology · doi:10.1530/eje-09-0044 · Cited by 253 · see citing works
Self-citation(2017) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2017-7008 · Cited by 249 · see citing works
The interface between thyroid and diabetes mellitus
Duntas, L. H., Orgiazzi, J., & Brabant, G. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04029.x · Cited by 247 · see citing works
Evidence for Leptin Binding to Proteins in Serum of Rodents and Humans: Modulation With Obesity
Houseknecht, K. L., Mantzoros, C. S., Kuliawat, R., Hadro, E., Flier, J. S., & Kahn, B. B. (1996) · Diabetes · doi:10.2337/diab.45.11.1638 · Cited by 245 · see citing works
Thyroid hormone regulation of hepatic lipid and carbohydrate metabolism
Sinha, R. A., Singh, B. K., & Yen, P. M. (2014) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2014.07.001 · Cited by 241 · see citing works
Santini, F., Marzullo, P., Rotondi, M., Ceccarini, G., Pagano, L., Ippolito, S., Chiovato, L., & Biondi, B. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0067 · Cited by 240 · see citing works
Self-citationBayer, A. L., Yu, A., Adeegbe, D. O., & Malek, T. R. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041179 · Cited by 238 · see citing works
Insulin Action in Adipose Tissue and Muscle in Hypothyroidism
Dimitriadis, G., Mitrou, P., Lambadiari, V., Boutati, E., Maratou, E., Panagiotakos, D. B., Koukkou, E., Tzanela, M., Thalassinos, N., & Raptis, S. A. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0478 · Cited by 233 · see citing works
Introducing the Thyroid Gland as Another Victim of the Insulin Resistance Syndrome
Rezzónico, J., Rezzónico, M., Pusiol, E., Pitoia, F., & Nièpomniszcze, H. (2008) · Thyroid · doi:10.1089/thy.2007.0223 · Cited by 229 · see citing works
Marzullo, P., Minocci, A., Tagliaferri, A., Guzzaloni, G., Blasio, A. M. D., Medici, C. D., Aimaretti, G., & Liuzzi, A. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2798 · Cited by 229 · see citing works
Huber, A. K., Menconi, F., Corathers, S. D., Jacobson, E. M., & Tomer, Y. (2008) · Endocrine Reviews · doi:10.1210/er.2008-0015 · Cited by 228 · see citing works
Metabolic Effects of Thyroid Hormone Derivatives
Moreno, M., de Lange, P., Lombardi, A., Silvestri, E., Lanni, A., & Goglia, F. (2008) · Thyroid · doi:10.1089/thy.2007.0248 · Cited by 226 · see citing works
A high normal TSH is associated with the metabolic syndrome
Ruhla, S., Weickert, M. O., Arafat, A. M., Osterhoff, M. A., Isken, F., Spranger, J., Schöfl, C., Pfeiffer, A. F. H., & Möhlig, M. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2009.03698.x · Cited by 225 · see citing works
Männistö, T. I., Vääräsmäki, M., Pouta, A. M., Hartikainen, A., Ruokonen, A., Surcel, H., Bloigu, A. H., Järvelin, M., & Suvanto, E. T. J. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1904 · Cited by 216 · see citing works
Thyroid Dysfunction in Patients With Type 1 Diabetes
Umpierrez, G. E., Latif, K. A., Murphy, M. B., Lambeth, H. C., Stentz, F., Bush, A., & Kitabchi, A. E. (2003) · Diabetes Care · doi:10.2337/diacare.26.4.1181 · Cited by 215 · see citing works
Why Can Insulin Resistance Be a Natural Consequence of Thyroid Dysfunction?
Brenta, G. (2011) · Journal of Thyroid Research · doi:10.4061/2011/152850 · Cited by 212 · see citing works
Mitochondrial disease and endocrine dysfunction
Chow, J. C. K., Rahman, J., Achermann, J. C., Dattani, M., & Rahman, S. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.151 · Cited by 212 · see citing works
Bianco, A. C., Sheng, X. Y., & Silva, J. E. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)81340-6 · Cited by 206 · see citing works
Mentuccia, D., Proietti-Pannunzi, L., Tanner, K., Bacci, V., Pollin, T. I., Poehlman, E. T., Shuldiner, A. R., & Celi, F. S. (2002) · Diabetes · doi:10.2337/diabetes.51.3.880 · Cited by 205 · see citing works
Canani, L. H. S., Capp, C., Dora, J. M., Meyer, E. L. D. S., Wagner, M. S., Harney, J. W., Larsen, P. R., Gross, J. L., Bianco, A. C., & Maia, A. L. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1977 · Cited by 204 · see citing works
Mechanisms regulating GLUT4 glucose transporter expression and glucose transport in skeletal muscle
Zorzano, A., Palacı́n, M., & Gumà, A. (2005) · Acta Physiologica Scandinavica · doi:10.1111/j.1365-201x.2004.01380.x · Cited by 202 · see citing works
Energy balance regulation by thyroid hormones at central level
López, M., Álvarez, C. V., Nogueiras, R., & Diéguez, C. (2013) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2013.04.004 · Cited by 199 · see citing works
Jacobson, E. M., & Tomer, Y. (2007) · Journal of Autoimmunity · doi:10.1016/j.jaut.2007.02.006 · Cited by 198 · see citing works
Chen, G., Xu, S., Renko, K., & Derwahl, M. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1754 · Cited by 196 · see citing works
Fasting-Induced Changes in the Hypothalamus–Pituitary–Thyroid Axis
Boelen, A., Wiersinga, W. M., & Fliers, E. (2008) · Thyroid · doi:10.1089/thy.2007.0253 · Cited by 194 · see citing works
Hegedüs, L., Moses, A. C., Zdravkovic, M., Le Thi, T., & Daniels, G. H. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2318 · Cited by 194 · see citing works
Thyroid function and risk of type 2 diabetes: a population-based prospective cohort study
Chaker, L., Ligthart, S., Korevaar, T. I. M., Albert Hofman, D., Franco, O. H., Peeters, R. P., & Dehghan, A. (2016) · BMC Medicine · doi:10.1186/s12916-016-0693-4 · Cited by 194 · see citing works
Al-Adsani, H. (1997) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.4.1118 · Cited by 193 · see citing works
Relationship of Subclinical Thyroid Disease to the Incidence of Gestational Diabetes
Tudela, C. M., Casey, B. M., McIntire, D. D., & Cunningham, F. G. (2012) · Obstetrics and Gynecology · doi:10.1097/aog.0b013e318250aeeb · Cited by 192 · see citing works
Metabolic Syndrome and the Risk of Cardiovascular Disease in Older Adults
Butler, J., Rodondi, N., Zhu, Y., Figaro, K., Fazio, S., Vaughan, D. E., Satterfield, S., Newman, A. B., Goodpaster, B. H., Bauer, D. C., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.12.046 · Cited by 191 · see citing works
Bakker, S. J. L., ter Maaten, J. C., Popp‐Snijders, C., Slaets, J. P. J., Heine, R. J., & Gans, R. O. B. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.3.7324 · Cited by 190 · see citing works
Exercise and insulin cause GLUT-4 translocation in human skeletal muscle
Thorell, A., Hirshman, M. F., Nygren, J., Jorfeldt, L., Wojtaszewski, J. F. P., Dufresne, S. D., Horton, E. S., Ljungqvist, O. H., & Goodyear, L. J. (1999) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1999.277.4.e733 · Cited by 190 · see citing works
Chen, H. ‐., Wu, T. ‐. J., Jap, T. ‐., Lu, R. ‐., Wang, M. ‐., Chen, R. ‐., & Lin, H. ‐. (2007) · Diabetic Medicine · doi:10.1111/j.1464-5491.2007.02270.x · Cited by 189 · see citing works
Kavvoura, F. K., Akamizu, T., Awata, T., Ban, Y., Chistiakov, D. A., Frydecka, I., Ghaderi, A. A., Gough, S. C. L., Hiromatsu, Y., Płoski, R., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0147 · Cited by 183 · see citing works
Waring, A. C., Rodondi, N., Harrison, S. L., Kanaya, A. M., Simonsick, E. M., Miljkovic, I., Satterfield, S., Newman, A. B., Bauer, D. C., & for the Health, A. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04328.x · Cited by 181 · see citing works
Thyroid hormone excess and glucose intolerance
Dimitriadis, G., & Raptis, S. (2001) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-2001-18584 · Cited by 179 · see citing works
Cause-Specific Mortality in a Population With Diabetes
Roper, N. A., Bilous, R., Kelly, W. F., Unwin, N. C., & Connolly, V. M. (2002) · Diabetes Care · doi:10.2337/diacare.25.1.43 · Cited by 179 · see citing works
Intolerance to Statins: Mechanisms and Management
Bitzur, R., Cohen, H., Kamari, Y., & Harats, D. (2013) · Diabetes Care · doi:10.2337/dcs13-2038 · Cited by 178 · see citing works
Thyrotropin Suppression by Metformin
Vigersky, R. A., Filmore-Nassar, A., & Glass, A. R. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1210 · Cited by 174 · see citing works
Klieverik, L. P., Janssen, S. F., van Riel, A. C. M. J., Foppen, E., Bisschop, P. H. L. T., Serlie, M. J. M., Boelen, A., Ackermans, M. T., Sauerwein, H. P., Fliers, E., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805355106 · Cited by 174 · see citing works
TSH-Lowering Effect of Metformin in Type 2 Diabetic Patients
Cappelli, C., Rotondi, M., Pirola, I., Agosti, B., Gandossi, E., Valentini, U., De Martino, E., Cimino, A., Chiovato, L., Agabiti-Rosei, E., et al. (2009) · Diabetes Care · doi:10.2337/dc09-0273 · Cited by 173 · see citing works
Rugge, J. B., Bougatsos, C., & Chou, R. (2015) · Annals of Internal Medicine · doi:10.7326/m14-1456 · Cited by 172 · see citing works
Protein tyrosine phosphatase PTPN22 in human autoimmunity
Vang, T., Miletic, A. V., Bottini, N., et al. (2007) · Autoimmunity · doi:10.1080/08916930701464897 · Cited by 171 · see citing works
Thyroid Hormones, Gonadal and Adrenocortical Steroids and the Function of the Islets of Langerhans
Lenzen, S., & Bailey, C. J. (1984) · Endocrine Reviews · doi:10.1210/edrv-5-3-411 · Cited by 170 · see citing works
Circulating leptin and thyroid dysfunction
Zimmermann‐Belsing, T., Brabant, G. E., Holst, J. J., & Feldt‐Rasmussen, U. (2003) · European Journal of Endocrinology · doi:10.1530/eje.0.1490257 · Cited by 170 · see citing works
Incidence of Postpartum Thyroid Dysfunction in Patients with Type I Diabetes Mellitus
Gerstein, H. C. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-118-6-199303150-00004 · Cited by 169 · see citing works
Tian, L., Song, Y., Xing, M., Zhang, W., Ning, G., Li, X., Yu, C., Qin, C., Liu, J., Tian, X., et al. (2010) · Hepatology · doi:10.1002/hep.23800 · Cited by 168 · see citing works
Roef, G. L., Rietzschel, E. R., daele, C. M. V., Taes, Y., Buyzere, M. D., Gillebert, T. C., & Kaufman, J. (2013) · Thyroid · doi:10.1089/thy.2013.0314 · Cited by 167 · see citing works
Alvarez-Marfany, M., Roman, S. H., Drexler, A. J., Robertson, C., & Stagnaro-Green, A. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.79.1.8027213 · Cited by 167 · see citing works
Boekholdt, S. M., Titan, S. M., Wiersinga, W. M., Chatterjee, K., Basart, D. C. G., Luben, R., Wareham, N. J., & Khaw, K. (2010) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2009.03640.x · Cited by 167 · see citing works
Simvastatin Effects on Skeletal Muscle
Larsen, S., Stride, N., Hey-Mogensen, M., Hansen, C. N., Bang, L. E., Bundgaard, H., Nielsen, L. B., Helge, J. W., & Dela, F. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.09.036 · Cited by 165 · see citing works
Kong, W. M., Martin, N. M., Smith, K. L., Gardiner, J., Connoley, I. P., Stephens, D. A., Dhillo, W. S., Ghatei, M. A., Small, C. J., & Bloom, S. R. (2004) · Endocrinology · doi:10.1210/en.2004-0545 · Cited by 164 · see citing works
Vaur, L., Gueret, P., Lievre, M., Chabaud, S., Passa, P., & For the DIABHYCAR Study Group (2003) · Diabetes Care · doi:10.2337/diacare.26.3.855 · Cited by 163 · see citing works
Duntas, L. H., & Biondi, B. (2012) · Thyroid · doi:10.1089/thy.2011.0499 · Cited by 162 · see citing works
Self-citationKawasaki, E., Awata, T., Ikegami, H., et al. (2006) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.31124 · Cited by 161 · see citing works
Papazafiropoulou, A. K. (2010) · Journal of Clinical Medicine Research · doi:10.4021/jocmr2010.03.281w · Cited by 160 · see citing works
Brand, O. J., Lowe, C. E., Heward, J. M., Franklyn, J. A., Cooper, J. D., Todd, J. A., & Gough, S. C. L. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02762.x · Cited by 159 · see citing works
The regulation of Foxp3 expression in regulatory CD4+CD25+T cells: Multiple pathways on the road
Zhang, L., & Zhao, Y. X. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.21001 · Cited by 158 · see citing works
Thyroid dysfunction and serum lipids: a community‐based study
Walsh, J. P., Bremner, A., Bulsara, M. K., O'Leary, P. C., Leedman, P. J., Feddema, P., & Michelangeli, V. P. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02399.x · Cited by 158 · see citing works
Abbott, C. R., Rossi, M., Wren, A., Murphy, K. G., Kennedy, A. R., Stanley, S. A., Zollner, A. N., Morgan, D. G. A., Morgan, I., Ghatei, M. A., et al. (2001) · Endocrinology · doi:10.1210/endo.142.8.8304 · Cited by 158 · see citing works
TSH stimulates leptin secretion by a direct effect on adipocytes
Menendez, C. E. E. A., Baldelli, R., Camiña, J. P., Escudero, B., Peino, R., Diéguez, C., & Casanueva, F. F. (2003) · Journal of Endocrinology · doi:10.1677/joe.0.1760007 · Cited by 158 · see citing works
Duntas, L. H., & Wartofsky, L. (2007) · Thyroid · doi:10.1089/thy.2007.0116 · Cited by 157 · see citing works
The relationship between serum thyrotropin and components of metabolic syndrome
Lai, Y., Wang, J., Jiang, F., Wang, B., Chen, Y., Li, M., Liu, H., Li, C., Xue, H., Li, N., et al. (2010) · Endocrine Journal · doi:10.1507/endocrj.k10e-272 · Cited by 157 · see citing works
Pistrosch, F., Herbrig, K., Oelschlaegel, U., RICHTER, S., Passauer, J., Fischer, S., & GROSS, P. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.03.039 · Cited by 157 · see citing works
Excess thyroid hormone and carbohydrate metabolism
Potenza, M., Via, M. A., & Yanagisawa, R. T. (2009) · Endocrine Practice · doi:10.4158/ep.15.3.254 · Cited by 155 · see citing works
The role of leptin in the regulation of TSH secretion in the fed state: in vivo and in vitro studies
Ortiga-Carvalho, T. M., Oliveira, K. J., Soares, B., & Pazos-Moura, C. (2002) · Journal of Endocrinology · doi:10.1677/joe.0.1740121 · Cited by 154 · see citing works
Mohn, A., Michele, S. D., Luzio, R. D., Tumini, S., & Chiarelli, F. (2002) · Diabetic Medicine · doi:10.1046/j.1464-5491.2002.00635.x · Cited by 152 · see citing works
Body Fatness and Markers of Thyroid Function among U.S. Men and Women
Kitahara, C. M., Platz, E. A., Ladenson, P. W., Mondul, A. M., Menke, A., & de González, A. B. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034979 · Cited by 151 · see citing works
Thyroid Autoimmunity in Children and Adolescents with Type 1 Diabetes mellitus
Holl, R. W., Böhm, B. O., Loos, U., Grabert, M., Heinze, E., & Homoki, J. (1999) · Hormone Research in Paediatrics · doi:10.1159/000023446 · Cited by 149 · see citing works
Wang, X., Kakoulidou, M., Giscombe, R., Qiu, Q., Huang, D., Pirskanen, R., & Lefvert, A. K. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00228-x · Cited by 148 · see citing works
The Safety of Incretin-Based Therapies—Review of the Scientific Evidence
Drucker, D. J., Sherman, S. I., Bergenstal, R. M., & Buse, J. B. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0599 · Cited by 148 · see citing works
The role of leptin in glucose homeostasis
Denroche, H. C., Huynh, F. K., & Kieffer, T. J. (2012) · Journal of Diabetes Investigation · doi:10.1111/j.2040-1124.2012.00203.x · Cited by 147 · see citing works
Polyglandular autoimmune syndromes
Kahaly, G., & Frommer, L. (2017) · Journal of Endocrinological Investigation · doi:10.1007/s40618-017-0740-9 · Cited by 147 · see citing works
Self-citationThyroid dysfunction and thyroid autoimmunity in Saudi type 2 diabetics
Akbar, D. H., Ahmed, M. M., & Al-Mughales, J. (2006) · Acta Diabetologica · doi:10.1007/s00592-006-0204-8 · Cited by 146 · see citing works
Scope and limitations of iodothyronine deiodinases in hypothyroidism
Gereben, B., McAninch, E. A., Ribeiro, M. O., & Bianco, A. C. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.155 · Cited by 146 · see citing works
Hypothyroidism Is a Risk Factor for New-Onset Diabetes: A Cohort Study
Gronich, N., Deftereos, S., Lavi, I., Persidis, A., Abernethy, D. R., & Rennert, G. (2015) · Diabetes Care · doi:10.2337/dc14-2515 · Cited by 144 · see citing works
Chubb, S. A. P., Davis, W. A., Inman, Z., & Davis, T. M. E. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02246.x · Cited by 143 · see citing works
Morbidity before and after the diagnosis of hyperthyroidism: a nationwide register-based study
Brandt, F., Thvilum, M., Almind, D., Christensen, K., Green, A., Hegedüs, L., & Brix, T. H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066711 · Cited by 142 · see citing works
Flagged first, then by citations
Research works printed but not linked: 4
- Centers for Disease Control and Prevention, 2011, National Diabetes Fact Sheet: National Estimates and General Information on Diabetes and Prediabetes in the United States, 2011
- 2003, 26, 1181
- 2000, J Gorgan Uni Med Sci, 2, 5
- Efe, 1999, Effects of second generation sulfonylureas on the thyroid, Turk J Endocrinol Metab., 4, 173
Cited by
Sorted by citations
Frommer, L., & Kahaly, G. J. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00602 · Cited by 86 · see citing works
Self-citationLiu, Y.-J., Miao, H.-B., Lin, S., & Chen, Z. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1015516 · Cited by 49 · see citing works
Zang, L., Liu, X., Xie, X., Zhou, X., Pan, Y., & Dai, J. (2023) · Environmental Pollution · doi:10.1016/j.envpol.2023.121504 · Cited by 42 · see citing works
Jain, A. B., & Lai, V. (2024) · Diabetes Therapy · doi:10.1007/s13300-024-01628-0 · Cited by 32 · see citing works
Description of thyroid disorders the year before conception: a population-based study.
Tena Vivó, G., Parellada Esquius, N., Cunillera Puértolas, O., Albareda Riera, M., Isidro Albaladejo, M., & Vila Ballester, L. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1236505 · Cited by 6 · see citing works
The progression of secondary diabetes: A review of modeling studies
Yang, B., Li, J., Haller, M. J., Schatz, D. A., & Rong, L. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1070979 · Cited by 6 · see citing works
“Moreover, T3 exerts profound effects on the proliferation of pancreatic islet cells and insulin secretion (57, 59).”
BackgroundInfluentialWang, X., Zhang, M., Liu, Z., Li, C., Li, Y., Huang, H., He, H., & Yu, X. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1506664
“There are strong associations between diabetes mellitus and numerous concurrent health issues, such as osteoporosis, thyroid dysfunction, and abnormalities in iron metabolism (2 – 4).”
- Authors
- Biondi, B., Kahaly, G. J., & Robertson, R. P.
- Affiliations
- Federico II University Hospital (IT)
- University Medical Center of the Johannes Gutenberg University Mainz (DE)
- University of Washington (US)
- Corresponding author
- Biondi, Bernadette
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2019-01-14
- Volume
- 40
- Issue
- 3
- Pages
- 789-824
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- PMC
- PMC6507635
- OpenAlex
- W2909632761
- Semantic Scholar
- 5611ced84cb98c912f119fd45af52bec095d4953
- Cited by
- 598
- References
- 410
- Citations by year
- 2026: 81 · 2025: 105 · 2024: 120 · 2023: 107 · 2022: 98 · 2021: 50 · 2020: 28 · 2019: 9
- FWCI
- 7.09
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Endocrine Reviews (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (NIDDK RO-1 38325-35)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- thyroid dysfunction, diabetes mellitus, type 1 diabetes, type 2 diabetes, subclinical hypothyroidism, overt hypothyroidism, metabolic syndrome, thyroid hormone regulation, glucose metabolism, lipid metabolism, adipose tissue, pancreatic beta cells, skeletal muscle, autoimmune thyroid disease, susceptibility genes, antidiabetic drugs, treatment algorithm
- MeSH terms
- Animals, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Humans, Hypothyroidism, Thyroid Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-08.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-08.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review